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Triglyceride Synthesis in Normal 
and HyperapoB Fibroblasts
Katherine M. Cianflone, Ph.D.
Concordia University, 1989
The goal of this thesis was to examine the regulation 
of intracellular triglyceride synthesis from normals and 
HyperapoB patients using cultured skin fibroblasts as an 
experimental model. In a medium supplemented with 
lipoprotein-deficient serum, triglyceride synthesis and 
cholesterol esterification were reduced in the HyperapoB 
fibroblasts by 40% and 44% respectively as compared to the 
normal fibroblasts. These differences were due to differences 
in de novo synthesis, and not due to re-esterification or 
hydrolysis. However, unexpectedly, there was no difference 
in triglyceride synthesis between the cells from normals and 
HyperapoB when a serum-free supplemented medium was used.
The stimulatory factor in lipoprotein-deficient serum 
was then isolated from human plasma and characterized. The 
factor responsible is nondialyzable and trypsin sensitive, 
and its effects are both concentration and time dependent. 
The protein responsible has been purified to homogeneity and 
is a small ( MW 14,000), basic (pi 9.0) protein. It has been 
named Acylation Stimulating Protein (ASP) because it markedly 
stimulates triglyceride synthesis and cholesterol 
esterification by 80% and 42% in normal human skin 
fibroblasts. Further ASP is specifically bound with a KD of
9.9 x 10'7 and is internalized and degraded by normal human 
skin fibroblasts.
In contrast, ASP has much less effect on triglyceride 
synthesis in HyperapoB fibroblasts with an average of only 
25% triglyceride stimulation. This is consistent with its 
reduced maximal binding (51% of normal) and subsequent 
internalization into these cells. Although both cell groups 
demonstrate the same binding affinity for ASP (Scatchard 
analysis slope = -.0725 ug‘1 normal and - 080 ug'1 HyperapoB) 
the maximal number of apparent binding sites is reduced in 
HyperapoB (1.217 mg '1 normal vs 0.621 mg '1 HyperapoB). The 
ASP effect on cells from patients with Familial 
Hypercholesterolemia, however, is normal with regard to ASP 
stimulation of triglyceride synthesis (average 55% 
stimulation) and ASP binding to cells.
This research therefore has led to the description of 
a previously unrecognized protein in human plasma. This 
protein, ASP, appears to be the most potent stimulant of 
intracellular triglyceride synthesis yet described.
ACKNOWLEDGEMENTS 
Amino acid analyses were kindly performed by Dr. Jean 
Gagnon, Biotechnology Research Institute, Montreal, Quebec.
Dr. Mary Dempsey provided the Fatty Acid Binding 
Protein (FABP) used in the experiments.
Sections of this thesis have been published in the 
following articles:
1. Cianflone K, Kwiterovich P, Walsh M, Forse A, Rodriguez 
M, Sniderman A, Stimulation of fatty acid uptake and 
triglyceride synthesis in human cultured skin fibroblasts and 
adipocytes by a serum protein, Biochem Biophys Res Commun 144 
94-100, 1987.
2. Cianflone K, Rodriguez M, Walsh M, Vu H, Sniderman A, 
The effect of a plasma protein fraction on lipid synthesis 
in cultured skin fibroblasts from normals and patienrs with 
HyperapoB, Clin Invest Med H  99-107, 1988.
3. Cianflone K, Sniderman A, Walsh M, Vu H, Gagnon J, 
Rodriguez M, Purification and characterization of acylation 
stimulating protein, J Biol Chem 264 426-4 30,
(v)
ACKNOWLEDGEMENTS (continued)
I would like to thank Dr. M.J.Kornblatt and the members 
of my research committee for their helpful suggestions.
In particular, I would like to acknowledge the role of 
Dr. Kornblatt. She has always been generous with her time 
and support. In an area of research not specifically her own, 
she demonstrated unqualified committment to postgraduate 
education.
Lastly, I would like to thank Dr. Allan D. Sniderman, 
whose encouragement and direction were instrumental in the 
realization of this work.
(vi)
TABLE OF CONTENTS
Abstract (i i i)
Acknowledgements (v)
Table of Contents (vii)
List of Figures and Tables (x)
Abbreviations (xiii)
Introduction 1
1. Lipoprotein Metabolism 1
2. Atherosclerosis and Lipoproteins 4
3. Atherosclerosis and Apoproteins 5
4. Hyperapobetalipoproteinemia 7
5. Triglyceride Synthesis in Adipose Tissue 11
6. Triglyceride Synthesis in Fibroblasts 16
Thesis Rationale 19
Materials and Methods 22
1. Subjects studied 22
2. Skin Fibroblasts 2 3
2.1 Culture of Skin Fibroblasts 2 3
2.2 Lipid Synthesis: Pre-experimental 2 3
2.3 Lipid Synthesis in Fibroblasts 2 5
2.4 Analysis of Cellular Lipid Synthesis 26
(vii)
3. Purification and Characterization of ASP 28
3.1 Column Chromatography 28
3.2 Electrophoresis 3 0
3.3 Amino Acid Analysis 30
4. Lipid Synthesis and Metabolism of ASP 31
4.1 Experimental Conditions 32
4.2 Radiolabelling of ASP 33
4.3 Internalization and Degradation of ASP 34
4.4 Cell Homogenate Experiments 3 5
5. Statistical Analyses 35
Results 37
1. Lipid Synthesis in Serum Supplemented
vs Hormone Supplemented Media 37
1.1 Lipid Synthesis in Normal Fibroblasts 37
1.2 Normal vs HyperapoB in Serum Medium 4 0
1.3 Lipid Synthesis in Hormone Medium 50
1.4 Serum Medium vs Hormone Medium 53
1.5 Serum Effect on Triglyceride Synthesis
in Normal Fibroblasts 58
1.6 Discussion 64
( v i i i )
2. Purification and Characterization of ASP
(Acyiation Stimulating Protein) 68
2.1 Purification o* ASP 68
2.2 Phys Characteristics of ASP 7 5
2.3 Bioacti itv of ASP 79
2.4 ASP-Cell Interactions 88
2.5 ASP Metabolism 9 3
2.6 Discussion 99
3. ASP effect on HyperapoB and FH Fibroblasts 106
3.1 Triglyceride Synthesis in HyperapoB 106
3.2 ASP Binding to HyperapoB Cells 113
3.3 Cholesterol Esterification in HyperapoB 115
3.4 Triglyceride Synthesis in Cell Homogenates 117
3.5 ASP Effect in FH Fibroblasts 117





LIST OF FIGURES AND TABLES
9
Figure 1. Lipoprotein Metabolism 2
Figure 2. Fatty Acid Metabolism 12
Figure 3. Lipid Synthesis in Serum Medium 39
Figure 4. Lipid Synthesis: Normal vs HyperapoB 43
Figure 5. Lipid Hydrolysis 47
Figure 6. Cholesterol Esterification 49
Figure 7. Hormone Medium: Normal vs HyperapoB 51
Figure 8. Lipid Synthesis in Hornone Medium 52
Figure 9. Glucose Incorporation into Triglyceride 54
Figure 10. Lipid Synthesis: Oleate Concentration 59
Figure 11. Lipid Synthesis vs Time 60
Figure 12. Lipid Synthesis: Effect of LPDS Protein 61
Figure 13. Lipid Synthesis: Effect of Media 63
Figure 14. Isolation of Partially Purified Protein 69
Figure 15. Effect of Partially Purified Protein 72
Figure 16. Isolation of ASP 74
Figure 17. ASP: Molecular Weight and pi 76
Figure 18. ASP Effect on Triglyceride Synthesis:
Time Curve 81
Figure 19. ASP: Effect of Oleate Concentration 82
Figure 20. ASP: Effect of Concentration 84
Figure 21. ASP Effect on Cholesterol Esterification 85
Figure 22. Effect of Fatty Acid Binding Proteins 87
on Lipid Synthesis
(x)
Figure 23. ASP Preincubation: Effect on Triglyceride
Synthesis 89
Figure 24. ASP Specific Binding to Normal
Fibroblasts 91
Figure 25. Effect of Trypsin Treatment
on ASP Stimulation 92
Figure 26. ASP Stimulation of Triglyceride Synthesis,
ASP Internalization and Degradation 94
Figure 27. ASP Postincubation: Effect on Triglyceride
Synthesis 96
Figure 28. ASP: Effect of Blocking Endocytosis 95
Figure 29. Mechanism of Action of ASP 97
Figure 30. ASP Model 107
Figure 31. ASP Effect on Triglyceride Synthesis:
Normal vs HyperapoB 111
Figure 32. ASP Internalization and Degradation:
Normal vs HyperapoB 112
Figure 33. ASP Specific Binding: Normal vs HyperapoB 114 
Figure 34. ASP Cholesterol Esterification:
Normal vs HyperapoB 116
Figure 35. ASP Triglyceride Stimulation in
Cell Homogenates 118
Figure 36. ASP Triglyceride Stimulation:
Normal vs FH 122
Figure 37. ASP Specific Binding: Normal vs FH 123
Figure 38. ASP Binding Distribution in all Subjects 12 5 
Figure 39. ASP Binding vs ASP Triglyceride
(xi)













Plasma Lipids and Lipoproteins in Normal 
Subjects
Plasma Lipids and Lipoproteins xn HyperapoB 
Subjects
Oleate and Glucose Incorporation into 
Intracellular Triglyceride and Phospholipid 
Lipid Synthesis
Acetate Incorporation into Lipids 
Purification of ASP 
Physical Characteristics of ASP 
ASP Effect on Lipid Synthesis:
% Stimulation and Lipid Distribution 
Plasma Lipids and Lipoproteins in Normal 
Subjects
Plasma Lipids and Lipoproteins in 
HyperapoB Subjects 
Plasma Lipids and Lipoproteins 
in FH Subjects















A B B R E V I A T I O N S
apoB apoprotein B
ASP acylation stimulating protein
ATP adenine triphosphate





FABP fatty acid binding protein
FFA free fatty acid
FH familial hypercholesterolemia
G3P glycerol-3-phosphate
HDL high density lipoprotein
HSA human serum albumin
HyperapoB Hyperapobetalipoproteinemia
IDL intermediate density lipoprotein
IEF isoelectric focusing









SEM standard error of the mean
SER smooth endoplasmic reticulum
TG triglyceride




Cholesterol , esterified cholesterol and triglycerides 
are non-polar and, as such, they must be transported in blood 
in large complexes which also contain polar lipids and 
specific apoproteins, the latter with functions much beyond 
that of mere packaging. These complexes, which have been 
named lipoproteins (l: review), transport the non-polar
lipids in the circulation in a water soluble form and are 
synthesized mainly by the liver and intestine and are 
catabolized by hepatic and extrahepatic tissues (Figure 1).
Chylomicrons are the largest of these lipoproteins. They 
are synthesized by the intestine in order to transport 
dietary triglyceride and cholesterol from the small intestine 
to most of the tissues in the body. The triglycerides in 
these particles are hydrolyzed within the plasma compartment 
by the action of lipoprotein lipase (LpL), an enzyme attached 
to the endothelial surfaces but synthesized by adipocytes and 
other cells. The fatty acids (FFA) liberated during 
hydrolysis are used as an energy source by many cells, such 
as the heart or skeletal muscle, or alternatively are taken 
up by adipocytes and stored within them as triglycerides.The 
lipoprotein particles thus generated are referred to as 
chylomicron remnants; they are relatively enriched in 



































































































Very low density lipoproteins (VLDL) are also large 
triglyceride rich particles, synthesized in the liver, so as 
to transport both triglyceride and cholesterol from the liver 
to various tissues. Again, within the plasma compartment, 
VLDL triglycerides are hydrolyzed by lipoprotein lipase (and 
hepatic lipase) producing free fatty acids, and thereby 
generating a series of smaller, cholesterol-enriched 
lipoproteins, including intermediate density lipoproteins 
(IDL) and low density lipoproteins (LDL). LDL represents the 
end product of VLDL catabolism, although not all VLDL reach 
this stage, with LDL being the major cholesterol-transporting 
lipoprotein in plasma. LDL are then cleared from the plasma 
both through hepatic and peripheral tissues via interaction 
with a specific receptor, the B,E receptor.
Lastly, high density lipoproteins (HDL) appear to arise 
from several sources, including the liver and the intestine. 
In addition, HDL or HDL precursors are generated in the 
plasma compartment as a result of lipolytic processing of 
dietary chylomicrons. It has been suggested that the HDL may 
be involved in reverse cholesterol transport, a pathway 
whereby HDL acquire cholesterol from peripheral tissues and 
then transport the cholesterol either directly or indirectly 
to the liver for excretion (1).
3
It should be emphasized that these lipoproteins are each 
heterogenous in size and composition, characteristics that 
are based on the rich traffic of lipids and apoproteins 
between the various classes of lipoproteins mediated by 
plasma enzymes, transfer proteins, and by the apoproteins 
themselves.
2. ATHEROSCLEROSIS AND LIPOPROTEINS
Epidemiological studies indicate that heart disease is 
the major cause of death in the North American adult 
population (2). Heart disease kills more people each year 
than all forms of cancer combined. Population studies have 
taught us that factors such as blood pressure, diet, weight, 
exercise and smoking habits are important in determining 
susceptibility to cardiovascular disease (3). However both 
epidemiologic data and clinical observations have shown that 
these variables alone do not explain susceptibility to 
cardiovascular disease among individuals. A large number of 
studies have now documented the strong association between 
lipoprotein concentrations in plasma and heart disease (4). 
Thus LDL concentrations correlate positively with coronary 
risk (5) , whereas HDL correlate negatively with coronary risk 
(6) .
Additionally, if the question is looked at from the 
other side, and the prevalence of dyslipoproteinemias among 
survivors of myocardial infarction or among individuals with
4
angiographically documented atherosclerotic lesions is 
ascertained, a sizable proportion are found to have abnormal 
lipoprotein levels (7,8). Lipid or lipoprotein levels 
exceeding the 95th percentile of the population distribution 
are classified as hyperlipidemic. This prevalence within the 
coronary artery disease population is not surprising since 
atherosclerotic lesions, which cause narrowing of the blood 
vessels, are characterized by depositions of lipoprotein- 
derived cholesterol in and around the cells of the arterial 
wall in addition to enhanced cellular proliferation and 
fibrosis (9). Thus epidemiologic evidence strongly supports 
a role for lipoproteins in atherosclerosis. In fact, recent 
clinical trials have demonstrated that altering plasma 
lipoprotein concentration (lowering LDL and raising HDL) 
using both diet and drugs lowers cardiovascular mortality 
(10) and reduces the rate of progression of disease (11).
3. ATHEROSCLEROSIS AND APOPROTEINS
The lipoproteins contain not only lipids but apoproteins 
which serve a variety of functions. These apoproteins provide 
not only structural support for the lipoprotein particle, but 
are necessary for their synthesis and secretion (1). Some 
also act as cofactors or activators of certain enzymes 
associated with lipid and lipoprotein metabolism and 
facilitate the exchange of lipids between the particles 
ultimately targeting the specific lipoprotein to tissues and
5
cells through interactions with cellular receptors. In 1971, 
Alaupovic (12) was the first to suggest that apoproteins 
should be considered when evaluating lipid disorders.
Since then a large number of studies have shown a strong 
association between elevated LDL apoB (the major apoprotein 
of LDL) and the risk of coronary heart disease, regardless 
of whether LDL cholesterol was elevated or normal (13). 
Patients with elevated plasma LDL apoB levels have been 
classified into two groups; those with elevated LDL 
cholesterol, and those with normal LDL cholesterol. The 
classic example of the first is Familial Hypercholesterolemia 
(FH) , a disorder which is characterized by cholesterol- 
enriched LDL particles. This autosomal dominant disorder is 
due to any of a series of genetic defects in the LDL receptor 
all of which result in a greatly reduced plasma clearance 
rate of LDL. This pathway has been well characterized by 
Brown and Goldstein who received the Nobel Prize in 198 5 for 
their contribution to the receptor hypothesis concept (14). 
The prevalence of this disorder within the general population 
is one in 500 for the heterozygous form, and one in one 
million for the homozygous form, and even within the coronary 
artery disease population the prevalence is low indeed. It 
should be noted that a clearance defect can be of two types: 
one present at a tissue site, such as a decrease in a 
receptor (as described above), but yet another may be in the 
lipoprotein particle itself that causes it to interact with
6
lesser affinity with the receptor. The recently described 
disorder, defective B100, is an example of the latter. 
(15,16).
4. HYPERAPOBETALIPOPROTEINEMIA
A far more prevalent phenotype within the coronary 
artery disease population, initially characterized by (i) an 
elevated LDL apoB (greater than the 95th percentile), (ii) 
a normal or near normal LDL cholesterol and (iii) a low LDL 
cholesterol/ apoB ratio was first recognized by Sniderman et 
al (17) and was called hyperapobeta-lipoproteinemia. This 
disorder is common in patients with premature coronary heart 
disease (18) and is often familial (19) . 
Hyperapobetalipoproteinemia (HyperapoB) exhibits a number 
of similarities with another disorder, Familial Combined 
Hyperlipidemia. Familial Combined Hyperlipidemia was first 
described by Goldstein et al (20) and defined as both 
hypertriglyceridemia and hypercholesterolemia within the same 
family. More recently, this definition has been modified to 
include elevated plasma apoB (21) and it has been suggested 
that these two entities, Hyperapobeta-lipoproteinemia and 
Familial Combined Hyperlipidemia in fact usually represent 
two sides of the same entity (22).
The increased levels of apoB in plasma in HyperapoB 
appear to be due to hepatic overproduction of apoB containing 
lipoprotein particles (VLDL and LDL) (23,24) (Figure 1) as
7
opposed to increased levels resulting from decreased 
catabolism (14) as described previously in the case of FH. 
This evidence has been adduced from isotope kinetic studies 
that trace the input and exit of apoB containing lipoproteins 
within the plasma compartment (23,24). These studies are 
based on two characteristics of the apoB containing 
lipoprotein particles. First, there is only one apoB molecule 
per lipoprotein particle (25) and, second, unlike other 
apolipoproteins, the apoB molecule does not exchange between 
lipoproteins (26) , but remains with its original lipoprotein 
particle until it is catabolized. As a result, quantification 
of apoB disappearance kinetics using I (lodmated)
apoB in VLDL or LDL accurately mirror the metabolism of these 
lipoprotein particles (23,24). In contrast to the apoB 
molecule, however, the lipid moieties of these lipoproteins 
do exchange with other lipoproteins (27) . Specifically, in 
HyperapoB, the overproduction of hepatic particles results 
in an exaggeration of the normal neutral core-lipid exchange 
which occurs between circulating triglyceride-rich (i.e. 
VLDL) and cholesterol-rich (i.e. LDL) lipoproteins (28).
The increased net hepatic output of apoB lipoproteins 
may be the result of a primary or a secondary defect within 
the liver itself which results in overproduction of the 
lipoprotein components: apoB, triglyceride, cholesterol and 
phospholipid (Figure 1) . However the causes of primary 
hepatic lipoprotein overproduction are, to date, unknown.
8
One possible cause of primary hepatic overproduction and 
secretion of apoB is a reduced capacity of the apoB molecule 
to bind to its lipid components (cholesterol, cholesterol 
ester, triglyceride and phospholipid) thereby reducing its 
effectiveness as a hepatic lipid exporter. Such avenues have 
been extensively explored using the techniques of molecular 
biology to examine the apoB gene. In any gene there is 
normally a certain amount of organism to organism variation 
in the allelic forms of the gene and therefore the gene 
product, for example, a protein such as apoB. A particular 
variation may be associated with an anomaly in protein 
structure and function. A number of groups have therefore 
examined the genetic (allelic) variation of the apoB gene 
itself in order to find associations between genetic 
variations in apoB DNA sequence and increased levels of 
plasma apoB. To date, the results are not persuasive, with 
some studies demonstrating an association between certain 
gene alleles and elevated levels of apoB (29), results which 
are at variance with other studies (30). Secondary causes of 
lipoprotein overproduction have been felt to include obesity 
with a high caloric intake, diabetes mellitus, and probably 
the nephrotic syndrome (31,32).
Alternatively, the increased secretion of apoB 
lipoproteins may be a hepatic response to an increased flux 
of lipids, either fatty acids or cholesterol,into the liver. 
In the case of fatty acids, this phenomenon might occur if
9
the rate of free fatty acid uptake into peripheral tissue 
such as adipose tissue were reduced. This hypothesis is 
supported by the reduced rate of in vitro fatty acid uptake 
and esterification which has been observed in adipose tissue 
obtained from patients with HyperapoB (33). Similarly, in 
vivo studies have also shown a delay in the clearance of 
exogenously derived triglycerides (chylomicrons) in patients 
with HyperapoB (34), a finding which is consistent with a 
peripheral tissue defect in the uptake and esterification of 
fatty acids. This reduced rate of peripheral tissue uptake 
and the resulting increased delivery to the liver of fatty 
acids might explain the increased secretion of VLDL and, 
subsequently, increased levels of LDL as the liver strives 
to maintain lipid homeostasis. As a result, the frequency of 
hypertriglyceridemia in patients with HyperapoB is not 
surprising (18). A similar line of reasoning has appeared in 
previous reports which have pointed to abnormal adipose 
tissue metabolism in patients with hypertriglyceridemia with 
either triglyceride synthesis diminished or triglyceride 
hydrolysis increased (35-37).
5. TRIGLYCERIDE SYNTHESIS IN ADIPOSE TISSUE 
Extracellular fatty acids become available to the cell 
as a result of the hydrolysis of triglyceride rich particles 
(chylomicrons and VLDL) through the action of lipoprotein 
lipase. Lipoprotein lipase is synthesized by adipose tissue
1 0
and is attached to the endothelial cell surface where it is 
available to act on the lipoproteins in the circulation (38). 
Additionally, fatty acids bound to albumin are also present 
in the circulation and these also are available for uptake 
by the cell. Albumin acts as a transporter of fatty acids 
within the circulation, and almost all of the fatty acid 
present in the circulation is bound to albumin, to a maximum 
of 6 fatty acids bound per albumin molecule (39). Free fatty 
acids (FFA) can diffuse through the plasma membrane into the 
adipocyte by a non energy dependent process (Figure 2) . 
Traditionally it has been thought that this was the only mode 
of entry of fatty acids into the cell (40,41); however, 
recently, a 40 kD plasma membrane protein (R) has been 
isolated from liver and cardiac tissue which binds fatty 
acids, consequently, it has been suggested that this protein 

















































































V  8 £ © 
3 1
CL 
®  03 



























o £X > o N






1  © 
°
0  a>
O -D © II
 ^CD
® TJ





0  CL © ^
= ©- <D<3) 2
1  ®1 * © —
0 a> 
x  t: 












Once within the cell, the fate of the fatty acid varies. 
Fatty acid can be transported to the mitochondria, to be 
oxidized so as to supply metabolic energy for the cell (44). 
Alternately, they can be directed to the microsome (smooth 
endoplasmic reticulum or SER) where they can be used for 
synthesis of both phospholipids (PL) and glycerolipids 
(triglyceride and diglyceride)(45). Phospholipids are 
synthesized for immediate use in the cell, principally as 
structural components of membranes. Within the adipocyte, the 
major portion of the fatty acids are esterified to form 
triglycerides (TG), which are then stored in the cells as 
lipid droplets (38). These fatty acids within the 
triglycerides can then be recovered when necessary through 
the action of triglyceride lipase, which releases the fatty 
acids according to the energy demands of the organism. It has 
been suggested that fatty acid binding protein (FABP), an 
intracellular protein present in a wide range of tissues, 
including liver and intestine, may play a role in the 
transport of fatty acid from the plasma membrane to the 
target site (mitochondria or microsome)(46). This protein 
belongs to a family of small molecular weight proteins which 
bind and transport hydrophobic ligands through the cytosolic 
milieu (47) . Although these are principally thought to be 
intracellular proteins, preliminary evidence has suggested 
that some of these proteins may also be secreted (48,49).
1 3
At the endoplasmic reticulum, the fatty acids are first 
activated by the action of acyl CoA ligase to form acyl 
Coenzyme A (FA-CoA), and then sequentially esterified to a 
glycerol-3-phosphate (G3P) backbone in a series of tightly 
linked enzymatic reactions to form the end product, which, 
in the case of neutral lipid synthesis, is triglyceride 
(TG)(39),(Figure 2). Adipose tissue makes an important 
contribution to the overall metabolism of an organism through 
its ability to store fatty acids as triglycerides and then 
to make these metabolites available again when required (38) . 
It is obviously important that the two opposing processes, 
fatty acid esterification and triglyceride hydrolysis, should 
be maintained under tight metabolic control (50).
A considerable body of knowledge exists concerning the 
direct activation of adipose tissue lipolysis by several 
hormones and the ability of insulin to antagonize these 
effects. On the other hand, current ideas about the control 
of triglyceride synthesis are concerned essentially with 
regulation of the supply of precursors to fat cells 
(50:review). With respect to hormonal regulation, one might 
predict that lipolytic hormones should inhibit 
esterification. In fact it is known that epinephrine, 
glucagon, adrenocorticotrophic hormone and thyroid 
stimulating hormone actually stimulate esterif ication as well 
as lipolysis (50) , perhaps as a result of the release of free 
fatty acids. There is, however, considerable evidence that
14
insulin can increase the rate of triglyceride synthesis in 
adipose tissue, an effect that is not secondary to increased 
glucose uptake (50). The activity of lipoprotein lipase, the 
enzyme that initially determines fatty acid supply to the 
cell, appears to be subject to hormonal control, as are also 
several of the enzymes in the triglyceride synthetic pathway: 
acyl CoA ligase, glycerol phosphate acyltransferase (gpat), 
phosphatidate phosphatase and diacylglycerol acyltransferase 
(Figure 2). The rate-limiting step in this pathway has not 
been clearly identified largely because the enzymes and 
intermediates are membrane-bound, and the mechanism of 
hormonal effect has not been elucidated, although it has been 
postulated that covalent modification of the enzymes involved 
in triglyceride synthesis by phosphorylation- 
dephosphorylation may be involved (50).
Although adipose tissue is the tissue of interest with 
respect to triglyceride synthesis and storage within cells, 
methodological difficulties are encountered when working with 
these cells. For example freshly isolated adipocytes, which 
are normally used, may still be subject to previous 
influences within the organism from which they were obtained 
(51) . Additionally, the adipocyte membrane functions are 
suspect due to the collagenase treatment used in the 
isolation procedure. Unfortunately, differentiated adipocytes 
are non-proliferating cells, and cannot therefore be
1 5
maintained in tissue culture for extended periods of time for 
repeated analysis.
6 . TRIGLYCERIDE SYNTHESIS IN FIBROBLASTS
Human skin fibroblasts do not synthesize and store 
significant triglyceride in the absence of extracellular 
fatty acid (52) . However, in the presence of an external 
fatty acid challenge, fibroblasts show a marked increase in 
lipid droplets and the accumulation of neutral lipid (52). 
Fibroblasts, therefore, have been examined as a potential 
model system for lipid synthesis. There is exchange of newly 
synthesized phospholipids with the preexisting phospholipid 
pool, however there is no net increase , whereas there is a 
net increase in triglyceride mass (52). A number of more 
recent studies have confirmed the classic earlier work which 
characterized cellular phospholipid as the "element constant" 
and cellular triglyceride as the "element variable". 
Triglyceride synthesis in fibroblasts appears tr be under 
similar hormonal regulation as in adipose tissue, since it 
has been reported that insulin also increases triglyceride 
synthesis in fibroblasts (53), whereas epinephrine increases 
lipolysis (54).
Human skin fibroblasts have been widely used as a model 
of peripheral tissue to examine a variety of intracellular 
metabolic functions including DNA synthesis (55), protein 
synthesis, lipid synthesis (52) and extracellular
16
interactions involving hormonal influences and transport 
processes via plasma membrane receptors. The classical 
example of the latter is the developement of the LDL receptor 
hypothesis and its implications with respect to cellular 
lipid biosynthesis, lipoprotein metabolism and the 
atherosclerotic disease process (14). Other transport 
mechanisms with carrier functions, such as the transferrin 
receptor (56) and the asialoglycoprotein receptor have also 
been extensively examined using fibroblasts. The effect of 
hormones such as insulin (53) and epinephrine (54) has also 
been studied.
Classically, a peptide hormone action has been defined 
as the direct action of a protein on a cell mediated through 
an interaction principally on the plasma membrane itself. 
That is to say, it is not a requirement for the hormone to 
be endocytosed by the cell in order for there to be a 
consequent response. In contrast, a protein that functions 
as an extracellular transport protein to deliver a ligand to 
the cells must be endocytosed and processed in order to see 
a metabolic effect on the cell. Various experimental 
manipulations have been developed, therefore, in order to 
investigate the mechanism of action of proteins on 
fibroblasts. To differentiate a plasma membrane effect from 
an effect mediated subsequent to endocytosis, the process of 
internalization and processing can be blocked through the use 
of drugs such as monensin (57), chloroquine or by lowering
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the ambient incubation temperature of the cells to 17°C 
(58). These techniques have been used to investigate the 
effects of insulin (59), transferrin (56) and LDL (60), to 
name but a few. In conclusion, therefore, fibroblasts are a 
well-defined cell model which can be used to examine 




The initial observations of reduced peripheral lipid 
synthesis in HyperapoB patients have been pursued and are 
the subject of the present work. Although adipose tissue is 
the principal site of triglyceride storage in the body, 
differentiated adipocytes are not proliferating cells and 
can, therefore, not be maintained in cell culture on a long 
term basis. Accordingly, human skin fibroblasts were chosen 
to study, since they are a well characterized biological 
system with a demonstrated consistency as a model for 
lipoprotein metabolism. Although in the absence of fatty 
acids in the cell culture medium they do not initiate 
intracellular triglyceride synthesis and storage, they are, 
however, known to synthesize and store triglycerides in 
response to extracellular fatty acids (52). These properties 
were confirmed in the introductory stages of the project 
where triglyceride synthesis in normal human skin fibroblasts 
was examined with respect to various parameters. These 
initial studies were performed in the presence of medium 
supplemented with human serum depleted of lipoproteins.
These studies demonstrated that human skin fibroblasts 
from patients with HyperapoB incorporated oleate into 
triglycerides to a lesser extent than the normal human skin 
fibroblasts. In contrast, when triglyceride synthesis was 
examined in a medium devoid of serum, but supplemented with
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hormones, it was found that the discrepancy between the 
normal and the HyperapoB fibroblasts no longer existed.(61)
Examination of this paradox suggested that a factor 
present in serum was responsible for stimulation of 
triglyceride synthesis in the normal fibroblasts (62). 
Investigation of this lipogenic effect of serum on normal 
fibroblasts has led to the purification of a novel serum 
protein.
This protein has been named Acylation Stimulating 
Protein (ASP). ASP is a small (MW 14,000), basic (pi 9.0) 
plasma protein. (63). ASP stimulates triglyceride synthesis 
in normal human skin fibroblasts in a time and concentration 
dependent manner. In addition, the metabolic effect of ASP 
on cells appears to be mediated through specific receptor 
interaction and internalization of the protein. Preliminary 
evidence suggests that ASP does not appear to act as either 
a hormone or a fatty acid transport protein, yet its 
metabolic effect on triglyceride synthesis is greater than 
that reported for any other protein. This raises the 
possibility that ASP may be of physiologic importance in free 
fatty acid metabolism in humans. While the mechanism of ASP 
remains to be elucidated in further studies, the present work 
appears to be unique in that it is the first in which lipid 
synthesis has been stimulated to this extent by a purified 
human plasma protein acting on human cells.
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The studies mentioned above have established the effect 
of ASP on normal human skin fibroblasts. The metabolism of 
ASP and its effect on synthesis of triglycerides has also 
been examined in human skin fibroblasts derived from patients 
with HyperapoB and other hyperlipidemias associated with 
coronary heart disease. Of primary relevance is the response, 
or rather lack of response, to ASP characteristic of the 
HyperapoB fibroblasts. As indicated by binding studies this, 
in turn, may be the result of a compromised receptor 
complement. In contrast, in another patient group examined, 
6 patients with Familial Hypercholesterolemia (FH), both a 
normal metabolic response to ASP and an apparently normal 
complement of ASP receptors were evident in the cell studies. 
The normal response of the FH patient fibroblasts to ASP 
emphasizes the striking contrast provided by the HyperapoB 
cells. These findings may have implications, therefore, both 
for understanding the pathogenesis of HyperapoB as well as 





Plasma samples (12 ml) were obtained from 12 hour fasted 
subjects. These samples were collected into tubes containing 
EDTA (1 mg/ml anticoagulant ) and then were spun at 2000 rpm 
for 15 minutes to obtain plasma. In all, 10 normal subjects 
and 19 patients were examined. Plasma triglycerides and 
plasma cholesterol were measured with commercially available 
colorimetric enzymatic kits (Boehringer Mannheim,Germany). 
HDL cholesterol was measured in the supernatant following 
precipitation of apoB containing lipoproteins with heparin 
and magnesium sulphate according to Lipid Research Clinic 
methods (64). LDL cholesterol was calculated by the method 
of Friedewald (65). LDL apoB was measured by radial 
immunodiffusion (66). All normal subjects were in good health 
and all had plasma lipid and lipoprotein values within the 
normal range as defined by the Lipid Research Clinics study 
(67), and an LDL apoB < 120 mg/dl. All HyperapoB patients had 
an LDL apoB greater than 120 mg/dl with an LDL cholesterol 
to apoB ratio of less than 1.5:1 (68). Familial
Hypercholesterolemia patients were defined as patients with 
an elevated total plasma cholesterol, elevated LDL 
cholesterol, LDL apoB, and an LDL cholesterol to LDL apoB 
ratio of greater than 1 .8:1 (68) or, diagnosed based on
the absence of functional LDL receptors, in the case of cells
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obtained from the American Tissue Culture Collection (ATCC) 
cell bank.
2. SKIN FIBROBLASTS
2.1 CULTURE OF SKIN FIBROBLASTS
All subjects had forearm skin biopsies from which the 
fibroblasts were cultured according to standard techniques 
(69). All tissue culture media and solutions were obtained 
from Flow Laboratories. The cells demonstrated the 
characteristic elongated and flattened out appearance seen 
in fibroblasts. Cells were maintained in Eagle's Minimum 
Essential Medium supplemented with 10% (v/v) fetal calf serum 
and 100 IU of penicillin- streptomycin at 37° in a 5% C02 
humid incubator. The cells were routinely subcultured at 
confluency in a 1:1 or 1:2 split ratio. Cells were detached 
from the wall of the flask by incubating with 0.25% trypsin 
in phosphate buffered saline (PBS) for 10 mins at 37°. Cell 
lines were used for experiments between passages 5 to 17. 
Prior to experiments, cells were dissociated in 0.25% trypsin 
(as above) and plated into 60 mm tissue culture treated 
dishes at a concentration of 1 x 105 cells per dish in 2.0 ml 
of medium (as described above). The experiments were 
initiated 6 days later.
2.2 LIPID SYNTHESIS: PREEXPERIMENTAL CONDITIONS
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The general format for the experiments was the same in 
all cases : (1) On day 6 (following plating out of the cells 
on day 1 as described above), the medium was changed to 1.0-
2.0 ml of a preincubation medium for 24 hours. This 
preincubation medium contained no radioactive oleate or other 
tracer.
(2) On day 7, radioactive tracer, usually U C oleate, 
was added to the cells and the incubation continued at 37°C 
for the indicated time periods. Following the incubation, 
the cells were harvested and analysed. All points for each 
cell line were always done in duplicate or triplicate (where 
indicated).
Preincubation medium consisted of either Eagle's Minimum 
Essential Medium supplemented with 2.5 mg protein/ml of 
lipoprotein- deficient serum (70) or a serum-free hormone 
supplemented medium (71). Lipoprotein-deficient serum is the 
plasma fraction with a density greater than 1.21 gm/ml, the 
lipoproteins having been removed by ultracentrifugation at 
100,000g for 40 hours (72). This fraction was recentrifuged 
at 100,OOOg for 24 hours, dialyzed against isotonic saline 
(.15M NaCl), and defibrinated by incubation at 24°C with 20 
IU/ml of thrombin followed by centrifugation (2000 rpm for 
15 min) to remove the clot, with the final lipoprotein 
deficient serum concentration adjusted to 50 mg/ml protein. 
All plasma used to generate lipoprotein-deficient serum had 
normal levels of lipids and lipoproteins as defined above.
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Free fatty acid concentration in the lipoprotein deficient 
serum was measured by enzymatic colorimetric method (Wako 
Chemicals, Japan) and the amount present was taken into 
account for calculation of specific activity in all the 
experiments.
The serum-free hormone supplemented medium consisted of 
a 1:1 mixture of Dulbecco's Minimum Essential Medium and 
Ham's F12 medium supplemented with 1% nonessential amino 
acids, 2.5 ug/ml insulin, 8 ug/ml biotin, 8 ug/ml calcium 
pantothenate, 5 ug/ml transferrin, 5 pg/ml triiodo-thyronine, 
and 17 ng/ml hydrocortisone as described by Amarosa, (71) 
100 IU/ml penicillin-streptomycin and, where indicated, 1.25 
mg/ml human serum albumin.
LDL was added to the preincubation medium for 
measurement of cholesterol esterification. LDL was isolated 
on a discontinuous gradient between densities 1.019 and 
1.063 g/ml by preparative ultracentrifugation (72) using 
NaCl-KBr solution with ImM EDTA, then recentrifuged and 
dialyzed against isotonic saline (.15M NaCl).
2.3 LIPID SYNTHESIS IN FIBROBLASTS
For the experimental incubation, on day 7, (1-U C) oleate 
(52.6 mCi/mmol, New England Nuclear) in ethanol was 
evaporated to dryness under a stream of nitrogen and 
resuspended in a solution of 10 mM sodium oleate complexed 
to albumin (73) ( with a molar ratio of oleate to albumin of
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6:1) to yield an average specific activity of 4.1 dpm/pmol. 
Aliquots were added to the cells at the indicated 
concentrations of oleate. In some cases, D-(6-3H(N)) glucose 
(31.2 Ci/mmol, New England Nuclear) or (Me-3H) thymidine 
(20.0 Ci/mmol, New England Nuclear) were also used as 
tracers in conjunction with radiolabelled oleate. Radioactive 
glucose was added to medium which in all cases contained 5.1 
mM glucose to yield a final specific activity of 0.8 
dpm/pmol. For determination of endogenous lipid synthesis in 
the absence of exogenous fatty acid (oleate), U C acetate was 
included in the media at a concentration of 1 mM, specific 
activity 1.21 dpm/pmole (74). Oleate incorporation into 
lipids was measured following incubation in a 5% C02 humid 
incubator at 37°C for the times indicated.
2.4 ANALYSIS OF CELLULAR LIPID SYNTHESIS
Following the incubation, the cells were then washed 
three times with cold 0.02 M phosphate buffered saline (PBS), 
harvested by scraping with a rubber policeman in 2 ml of PBS, 
and aliquots (usually 0.5 ml of 2.0 ml total) removed for 
protein determination and counting in a scintillation 
counter. Cell protein was dissolved in 0.1 N NaOH and the 
protein content was determined by a modified Lowry assay for 
membrane protein (75) using bovine serum albumin as a 
standard. The range in protein content per dish was 30-70 ug 
cellular protein.
2 6
The remaining sample (1.5 ml) was extracted with a 5- 
fold volume of chloroform: methanol: IN HC1 (20:10:0.25)
(76) . After 30 min, the sample was centrifuged (2000 rpm) 
for 10 min and the two phases separated. The organic phase 
was evaporated under a stream of nitrogen and redissolved in 
a small volume (100 uL) of chloroform: methanol (2:1). The 
lipids (cholesterol ester, triglyceride, fatty acid, 
diglyceride, cholesterol and polar lipids) were separated by 
thin layer chromatography (77) on Silica Gel G plates ( 
which were prewashed in chloroform: methanol 2 :1), in hexane: 
ether: acetic acid (75:25:1), along with lipid standards, and 
visualized by exposure to iodine vapour. The spots were 
scraped into vials containing scintillation fluid and 
counted in a liquid scintillation counter (Beckman 
Instruments). Counts were automatically corrected for 
quenching and channel overlap in dual label experiments with 
an automatic quench curve program. Results were expressed as 
average (+standard error of the mean (SEM)) nmoles of oleate 
incorporated per mg of cell protein.
Hydrolysis of cell lipids was measured following 
preincubation of cells for 24 hours in lipoprotein-deficient 
serum medium and then incubation with 100 uM 1-U C oleate in 
lipoprotein-deficient serum medium for 24 hours. The medium 
was then removed and the cells subsequently incubated for 2 
hours in serum-free hormone medium containing albumin as 
fatty acid acceptor, during which time the rate of lipid
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hydrolysis was determined. The cells were harvested and 
analysed as described above.
3. PURIFICATION AND CHARACTERIZATION OF ASP
3.1 COLUMN CHROMATOGRAPHY
ASP was purified by a three-step chromatographic 
procedure using normolipidemic defibrinated plasma.
STEP 1: Serum was applied to an Affigel-blue column 
(Biorad, California) at 1 g of serum protein (30 ml) per 100 
ml of gel. The gel was washed with 3 column volumes of buffer 
A (0.02 M phosphate buffer, pH 7.2) followed by elution of 
the bound protein with 3 M NaCl in buffer A. The column was 
regenerated with 6 M urea in buffer A and re-equilibrated 
with 5 volumes of buffer A. The eluted peak was concentrated 
by dialysis (using 10 kDa molecular weight cutoff dialysis 
tubing) against 50% polyethylene glycol and dialysed against 
buffer A to remove excess s jlt.
STEP 2: The concentrated protein from the first step 
was rechromatographed on a Sephadex G-75 (Pharmacia, Sweden) 
column. Following application, fractions were eluted with 
buffer A and the second peak, which emerged at Vg/V^ 3.4, was 
concentrated and dialyzed as above. This fraction emerged 
outside of the effective molecular weight range of the column 
as calibrated with albumin, beta-lactoglobulin, trypsinogen 




STEP 3: The concentrated fraction 2 (above), was
dialyzed against buffer B (0.025 M ethanolamine, 6 M urea, 
pH 9.7) and then applied to a PBE 96 chromatofocusing column 
(Pharmacia, Sweden). The column was eluted with Polybuffer 
96 (Pharmacia, Sweden) diluted 1:10 in 6 M urea, pH 5.8, 
until a pH of 7 was reached. The first peak that emerged, at 
an average pH of 8.9, contained 67% of the total activity 
recovered. The active fraction was concentrated, dialyzed 
against saturated ammonium sulphate to remove excess 
polybuffer, and then dialysed extensively for 24 hours 
against 4 changes of 1 L of buffer A. Since the polybuffer 
is difficult to remove completely, an alternate method was 
also used. Following gel filtration (step 2), the protein 
fraction was dialyzed against 0.02 M phosphate, pH 7.5 
(buffer C) and applied to an ion exchange CM Sepharose column 
(Pharmacia, Sweden). After washing with 3 column volumes of 
buffer C, the bound protein was eluted using 1 M NaCl in 
buffer C. The protein fraction was concentrated and dialyzed 
against buffer A. No differences in biological activity or 
physical properties were observed when the protein was 
isolated using either chromatofocusing or ion exchange 
chromatography. However, since the polybuffer might interfere 
with the amino acid analyses, for this purpose only samples 
purified by ion exchange chromatography were used. Aliquots 
of samples were frozen (-70°C) to minimize the aggregation 
which occurs when samples are maintained at 4°C.
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!3.2 ELECTROPHORESIS
Samples for electrophoresis were dialyzed against water 
and subsequently lyophilized. Lyophilized samples were 
redissolved in appropriate amounts of sample buffer (final 
protein concentration 1-2 mg/ml) and heated at 90°C for 5 
mins. For molecular weight determinations, samples were 
electrophoresed in (1) SDS, 6 M urea 12.5% PAGE gels under 
nonreducing conditions (78) or (2) SDS 15% polyacrylamide 
gels (PAGF) under reducing conditions (79) simultaneously 
with molecular weight standards from 92 to 14 kDa (Bio-Rad, 
California). For isoelectric point determinations, samples 
were electrophoresed in 8 M urea, 7.5% PAGE isoelectric 
focusing gels (80) with a pH gradient of 3 to 10 for 18 hours 
in parallel with appropriate standards of pi range 4.6 to 9.6 
(Bio-Rad, California). All gels were stained with Coomassie 
blue R250. Rf values and staining intensity were determined 
using a Transidyne RFT scanning densitometer (Transidyne 
Corporation, Michigan).
3.3 AMINO ACID ANALYSES
Aliquots of ASP purified by ion exchange chromatography 
and homogeneous by SDS PAGE for the 14,000 dalton protein 
were assayed for amino acid analysis by Dr Jean Gagnon of 
the Biotechnology Research Institute, Montreal, Canada. 
Samples were hydrolyzed at 150°C for 1,2,3 and 4 hours and
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analyzed for amino acid composition on a Beckman 7300 Amino 
Acid Analyzer (Beckman Instruments, California) using citrate 
buffer. For quantitation of methionine and cysteine, samples 
were first subjected to performic acid oxidation followed by 
hydrolysis for 1 hour. Both serine and threonine values were 
correced to zero time. Valine, isoleucine, and leucine were 
corrected for maximum yield. Optimum amino acid residue 
number was calculated by least deviation from integer. The 
protein concentration of samples for amino acid analyses was 
measured b ' both the modified Lowry assay (75), using bovine 
serum albumin (BSA) as a standard, and the Bradford assay 
(81), using both IgG and BSA as a standard. It was found that 
either the Lowry assay or the Bradford assay using BSA as 
standard yielded comparable results to the protein 
concentration determined by amino acid analysis. Accordingly, 
the Bradford assay using BSA as standard was chosen as the 
standard assay and was used consistently for all protein 
determinations of ASP and experiments involving ASP.
4. LIPID SYNTHESIS AND METABOLISM OF ASP
4.1 EXPERIMENTAL CONDITIONS
For experiments, cells were plated out at 1 x 105 cells 
per 60 mm dish as described above. On day 6 , cells were 
changed to a serum-free hormone supplemented medium without 
albumin. On day 7, (1-H C) sodium oleate (average specific
activity = 10 dpm/pmol) dissolved in isotonic saline was
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added to the medium at the specified concentrations. The 
concentration of free oleate added to the incubation medium 
did not exceed 25 uM, a value which is below the critical 
micellar concentration for oleate (40). In addition, serum 
fractions or purified ASP were added simultaneously at the 
indicated concentrations. In cells where no ASP was added, 
an equal amount of buffer was added to serve as a control. 
The cells were incubated for specified times at 37°C in a 
humid incubator and then harvested and analysed as described 
above. Incubations at 4°C (82) were performed by placing the 
cells on ,a layer of ice and maintaining the cells in a cold 
chamber for the duration of the experiment. Experiments 
performed at 17°C (58) were performed by placing the cells on 
a platform in a temperature controlled centrifugal chamber. 
The temperature was also monitored with an independent 
thermometer. C02 was piped into the chamber to maintain an 
appropriate C02 content. Mild trypsinization of the cells 
without detachment from the plate was performed by incubating 
the cells in trypsin solution (as described above) for 5 
minutes. Human serum albumin (HSA) was obtained from Sigma 
Chemicals, St. Louis. Fatty acid binding protein (FABP) was 
kindly provided by Dr. Mary Dempsey.
4.2 RADIOLABELLING OF ASP
For experiments on the metabolism of ASP, ASP was 
radioiodinated with 125iodine by the chloramine-T method of
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Elder (83). Briefly, 50-100 ug of ASP in 50 ul of 0.02 M 
phosphate buffer (buffer A) was mixed with 1 mCi of Na125I 
(in 10 ul) and 10 ul of 1 mg/ml chloramine-T in buffer A and 
vortexed at room temperature for 30 sec. Immediately, 10 ul 
of 10 mg/ml dithiothreitol and 150 ul of dialysis buffer were 
added to stop the reaction. The sample was then dialyzed 
extensively against dialysis buffer (0.02 M phosphate, pH 
7.4, .9% NaCl, 1 mM EDTA, 5 mM dithiothreitol and 1 mM Na
azide) for 24 hours against 4 changes of 1 L of buffer to 
remove excess 125I. The average specific activity obtained was 
79 cpm/ng protein. For binding of ASP to human skin 
fibroblasts, cells preincubated in hormone medium were 
precooled on ice (4°C) for 15 min. 125I ASP was added to the 
cells at the desired concentrations (average specific 
activity 12.4 cpm/ng) and incubated at 4°C for 2 hours. The 
medium was then removed from the cells which were washed 
and collected by scraping. The protein was then dissolved in
0.1 N NaOH for 1 hour. An aliquot of the cell suspension was 
taken for counting in a gamma counter, and for protein 
determination. Non-specific binding was measured by adding 
a 20 fold excess of unlabelled ASP prior to the addition of 
labelled ASP (82). Specific binding was calculated as the 
difference between total binding and non-specific binding. 
Results are expressed as ng ASP bound/ mg cell protein.
4.3 INTERNALIZATION AND DEGRADATION OF ASP
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Cells were preincubated in serum-free hormone media for 
24 hours, followed by incubation at 37°C for 4-24 hours in 
the presence of (1-H C) oleate and 125I ASP at the indicated 
concentrations. Following the incubation, the medium was 
removed, the cells washed and harvested by scraping. Aliquots 
of the cell suspension were removed for 125I counting in a 
gamma counter and for protein determinations, and the 
remaining sample was extracted in chloroform: methanol: HCl 
as described above for lipid analyses.
ASP degradation products in the medium were measured 
following addition of 1 mg/ml bovine serum albumin (final 
concentration) as a carrier protein and precipitation of
• • 125 •remaining I ASP with 60% trichloroacetic acid (final 
concentration 10%) (84). Following centrifugation (2000 rpm 
15 min), free iodine was subsequently removed from the 
supernatant by a second precipitation with 5 % AgN03 (final 
concentration 1.7%). The supernatant (after centrifugation 
as above) contains the degradation products, and an aliquot 
was counted in a gamma counter in a volume of 0.5 ml.
4.4 CELL HOMOGENATE EXPERIMENTS
Experiments measuring lipid synthesis in cell 
homogenates were performed essentially as described by Brown 
and Goldstein (60). In summary, cells were trypsinized (as 
above) , collected and homogenized in a 200 mM Tris HCl 
buffer, pH 7.4. Aliquots of cell homogenate were incubated
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in a filial volume of 200 uL with 2.5 mM ATP, 10 mM MgCl2, 1 
mM dithiothreitol, 0.5 mM Coenzyme A, 0.4 mM glycerol-3- 
phosphate and 20 uM U C oleate. After a 30 minute incubation, 
the reaction is stopped by extraction with isopropanol: 
heptane (1:1). The neutral lipids are extracted and analysed 
by TLC as described above.
5. STATISTICAL ANALYSES
All results are expressed per mg cell protein. Averages, 
standard deviation and S.E.M. (standard error of the mean) 
were calculated using standard methods. For comparison 
purposes, mean t tests were used to compare different cell 
lines from the control and patient groups, and paired t tests 
were used to compare results within cell lines.
In the figures, except as noted in the figure legends, all 
smooth lines were drawn for ease of visualization and the 
data were not fit to any specific equation. Where indicated 
in the figure legends only, some lines were drawn based on 
linear regression analysis and the equations for these lines 
are given in the figure legends in the form y=ax+b where a= 
slope and b= y axis intercept with the appropriate 
correlation coefficients (r) given. Scatchard analysis for 
specific binding of proteins to the fibroblasts was performed 
according to the method of Scatchard (85). Significance 




1. LIPID SYNTHESIS IN SERUM SUPPLEMENTED VS HORMONE 
SUPPLEMENTED MEDIUM
1.1 LIPID SYNTHESIS IN NORMAL FIBROBLASTS
Hunan skin fibroblast cell lines were established in 
the laboratory. All normal subjects were adults in good 
health with normal lipid and lipoprotein profiles. The 
individual plasma lipid and lipoprotein values are shown in 
Table I. These normal skin fibroblasts were then examined 
for their ability to consistently synthesize triglycerides 
and other lipids to a measurable extent for use as a cell 
model. Cells were prepared for the experiments as described 
in Materials and Methods using the medium supplemented with 
lipoprotein-deficient human serum (referred to as SERUM 
medium) for both preincubation and incubation. Since various 
lipoproteins are known to affect endogenous lipid synthesis, 
particularly in the case of triglyceride and cholesterol 
synthesis, it is important to remove all of the lipoproteins 
from the human serum before use in order to examine intrinsic 
intracellular lipid synthesis. The cells incubated in the 
presence of 100 uM oleate complexed to albumin (molar ratio 
6 :1) synthesized triglyceride and phospholipid at a linear 
rate over 24 hours as shown in Figure 3A. Different fatty 
acid concentrations were also examined for their effect on 
the amount of lipid synthesized over a 24 hour incubation 
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Figure 3B, triglyceride synthesis increased linearly up to 
the maximum concentration assayed of 500 uM oleate (complexed 
to albumin at a 6:1 molar ratio in all cases. Phospholipid 
synthesis however, remained fairly constant at all 
concentrations examined.
For the ensuing studies, therefore,a concentration of 
100 uM oleate was chosen since this concentration produced 
a readily quantifiable amount of triglyceride well within 
the linear portion of the concentration curve.
1.2 NORMAL VS HYPERAPOB IN SERUM MEDIUM
The plasma profiles for the HyperapoB patients examined 
are shown in Table II. One patient with HyperapoB had plasma 
triglyceride levels greater than the 95th percentile, one had 
plasma cholesterol and LDL cholesterol greater than the 95th 
percentile, wnile two of seven patients had HDL cholesterol 
values below the 5th percentile. However, average age, total 
plasma cholesterol, LDL cholesterol, and HDL cholesterol did 
not differ statistically between the normal and HyperapoB 
groups, although a trend towards higher plasma levels was 
evident in the HyperapoB patients (Table II). Plasma 
triglyceride levels were slightly higher in the HyperapoB 
patients than in the controls (p<0 .01). and there was a 
marked difference in their plasma LDL apoB levels, with the 
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of the normal group (159+10 vs 86+8 mg/dL p<.0005). (1-UC) 
Oleate incorporation into triglyceride, diglyceride, and 
phospholipid was measured in the normal and HyperapoB cells 
at three different time intervals. These three lipids 
constitute more than 95% of the create incorporated into the 
cells. The results are shown in Figure 4. At 30 minutes there 
is no difference in lipid synthesis between normal and
HyperapoB cells; however at this point very little lipid has 
been synthesized. At both 6 hours and 24 hours there is a 
substantial difference in the amount of diglyceride and
triglyceride synthesized in the HyperapoB cells as compared 
to the normal cells. At 24 hours in the HyperapoB cells, 
diglyceride levels are 64% (p<0.005) and triglyceride levels 
are 60% (p<0.0025) of the normal. Although there is a trend 
towards less phospholipid synthesis in the HyperapoB cells, 
it does not reach statistical significance.
These differences in synthesis determined solely on the 
basis of (1-U C) oleate incorporation into triglyceride might 
have been attributable to different rates of re-
esterification of diglyceride following partial hydrolysis 
of a pre-existing triglyceride pool, rather than to 
differences in de novo synthesis. To examine these 
possibilities both normal and HyperapoB fibroblasts were
incubated simultaneously with (1-U C) oleate and D-(6-3H(N)) 


























presence of 100 uM oleate complexed to albumin, cells were 
analysed for lipid content, and the molar amounts of (1-U C) 
oleate and (3H) derived from glucose contained in each lipid 
fraction were measured. The theoretical ratio of (U C) : (3H) of 
6:1 for triglyceride is calculated as follows. The three 
incorporated fatty acids have an equal chance of being 
radioactive. The 6 carbon glucose, labelled in the first 
carbon position only, will be split into a radioactive and 
a non-radioactive glycerol-3-phosphate pair for use as the 
triglyceride backbone. Significant re-esterification of a 
pre-existing pool would have resulted in a ratio greater than 
the theoretical one. As seen in Table III, these ratios for 
triglyceride in normal and HyperapoB cells are 4.5+0.4 and 
5.2+0.3, respectively, both very close therefore to the 
theoretical ratio. Note though that significantly less (UC) 
oleate is incorporated into triglyceride in the HyperapoB 
cells as compared to normal cells (p<0.05), a finding which 
is confirmed when glucose derived (3H) incorporation into 
triglyceride is examined (p<0.01). Similarly, in the case of 
phospholipids, although the theoretically expected ratio 
cannot be calculated because the phospholipids represent a 
variety of molecular species, the ratios are the same in both 
the normal and the HyperapoB cells. Thus the difference in 
triglyceride synthesis between normal and HyperapoB cells 
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The differences between normal and HyperapoB cells in 
serum medium suggest that there is an effect on triglyceride 
synthesis or triglyceride hydrolysis to which normal and 
HyperapoB cells respond differently. Net oleate incorporation 
into triglyceride is a function of the rates of both 
triglyceride synthesis and hydrolysis. Lipid hydrolysis was 
examined in the following experiment: cells were preincubated 
in serum medium with 100 uM (1-U C) oleate complexed to 
albumin in order to establish a pool of substrate available 
to lipase and thus allow the lipase to act maximally. 
Following this, cells were incubated for 2 hours in serum- 
free medium with albumin but no oleate present. The medium 
was analysed for (U C) oleate released from the cells, and the 
cells extracted to measure the amount of (1-U C) oleate 
remaining within them. The results are shown in Figure 5 . 
Note that there is a greater amount of lipid-associated (1- 
14C) oleate in the normal cells than in the HyperapoB cells, 
both before and after incubation. Thin layer chromatography 
(not shown) of the total cell lipids indicates that there is 
more (U C) triglyceride in the normals compared with the 
HyperapoB cells (90 + 5.3 vs 76 + 4.2 nmol/mg cell
protein,p<0.02 5) after the 2 hour hydrolysis period whereas 
there is no difference in (14C) phospholipids (54 + 5 vs 50 
+ 8 nmol/mg cell protein, p NS). The amount of (UC) oleate 


























































































































































































































sane in both normal and HyperapoB cells. Therefore, 
hydrolysis of lipids occurred at the same rate in both normal 
and HyperapoB cells.
Fatty acids are not only esterified to glycerol-3- 
phosphate to form storage triglycerides, but can also be 
linked to cholesterol to form cholesterol ester, which can 
be stored intracellularly (Figure 2). Therefore this 
reaction, cholesterol esterification, was also examined. In 
the absence of LDL in the medium, cholesterol ester synthesis 
in fibroblasts is minimal (71). Following preincubation in 
the presence of LDL, which results in cholesterol influx into 
the cells, cholesterol ester synthesis does increase 
substantially although (1-H C) oleate incorporation into 
triglycerides and phospholipids still predominates. 
Cholesterol ester synthesis in normal fibroblasts was found 
to be linear up to 10 hours and was linear up to (H C) oleate 
and LDL concentrations of 150 uM and 150 ug/ml, respectively 
(data not shown) . Accordingly, cells were preincubated in 
serum medium with 100 ug/ml LDL followed by incubation with 
100 uM (U C) oleate for the indicated time periods. As shown 
in Figure 6, cholesterol esterification was significantly 
reduced in the HyperapoB cells by 44% and 36% at 3 and 6 
hours respectively (p<0.05).
These results have demonstrated that the HyperapoB cells 



































































































































to the synthesis and storage of two acylation products: 
cholesterol ester and triglyceride.
1.3 LIPID SYNTHESIS IN HORMONE MEDIUM
Lipid synthesis was examined in a serum-free hormone 
supplemented medium (referred to as HORMONE medium). This 
medium was devoid of serum but was supplemented with various 
vitamins and hormones including insulin, transferrin, biotin, 
Ca pantothenate and triiodothyronine as described in 
Materials and Methods. The amounts of hormones present were 
not necessarily at physiological concentration, but those 
shown by Amarosa et al (71) to maximize endogenous lipid 
synthesis. Assays indicated that optimal experimental 
conditions were similar to those chosen for lipid synthesis 
in serum medium (figure 3) as further discussed in section 
1.5 (figures 10,11). Lipid and triglyceride synthesis 
increased up to 24 hours and 150 uM (U C) oleate in normal 
cells (data not shown).
Lipid synthesis was examined in both normal and 
HyperapoB cells using the hormone medium in both 
preincubation and incubation stages. As shown in Figure 7, 
in contrast to the findings using serum mt .ium (Figure 4), 
lipid synthesis was the same in both the normal and HyperapoB 
fibroblasts. This was the case for triglyceride, diglyceride, 
and phospholipid synthesis (Figure 7) at all the time points 
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the normal and HyperapoB cells in hormone medium was 
confirmed using two other concentrations of (U C) oleate, 50 
uM and 150 uM, both within the linear range of lipid 
synthesis and these results for triglyceride are shown in 
Figure 8A and 8B. Similarly there was no difference in 
phospholipid synthesis. Determination of (3H) glucose 
incorporation into triglycerides at these same oleate 
concentrations (50 uM, 100 uM and 150 uM) also demonstrated 
no difference between normal and HyperapoB cells (Figure 9). 
Additionally, the (U C)oleate : (3H) glucose ratio ranged from 
6.3 +.7 in the normals and 6.8 + .4 in the HyperapoB, close 
to the theoretical ratio of 6:1 as discussed above, 
reinforcing the conclusion that, in fact, in hormone medium 
there is no difference in the rate of triglyceride synthesis 
between the normal and HyperapoB fibroblasts.
1.4 SERUM MEDIUM VS HORMONE MEDIUM
Lipid syntheses in serum medium vs hormone medium at 
24 hours and 100 uM oleate are directly compared in Table 
IV. Phospholipid synthesis in both cell groups was the same 
in either medium. However, in normal cells triglyceride 
synthesis is greater in serum medium than in hormone medium 
(p<0.05) whereas, by contrast, in HyperapoB cells, 
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The search for other differences between normal and 
HyperapoB cells and between serum and hormone medium was 
pursued. The possibility that the difference in triglyceride 
synthesis might be due to different levels of intracellular 
glucose, the precursor to glycerol-3-phosphate, was explored. 
In experiments using labelled 3H glucose to determine 
incorporation into triglyceride (as described above), the 
total amount of labelled cellular glucose in the cell 
suspension was also measured. Levels of cellular (3H) glucose 
and (3H) glucose derived products were the same in both 
normal and HyperapoB cells either with serum medium or 
hormone medium (910+ 71 Normal vs. 900 +28 HyperapoB nmol/mg 
cell protein in serum medium; 802 +115 Normal vs. 949 +46 
HyperapoB nmol/mg cell protein in hormone medium).
Basal levels of endogenous fatty acid and lipid 
synthesis , that is, lipid synthesis in the absence of any 
added fatty acid in the medium, were also the same in normal 
cells and HyperapoB cells using either serum or hormone 
media. This is measured as (U C) acetate incorporation into 
the various cell lipids as shown in Table V. Similarly, no 
difference in (Me3H) thymidine uptake was detected. This is 
taken as an indication of DNA synthesis. Finally total 
amounts of cellular protein per tissue culture dish at the 
time of harvest were the same in both media. These last two 




























































































































































































































































proliferative effect as explanation for the increased lipid 
synthesis. Therefore, although a significant difference in 
triglyceride synthesis between normal and HyperapoB cells 
was evident in the presence of serum medium, that difference 
no longer existed in the presence of hormone supplemented 
medium. That difference was accordingly ascribed to a 
proposed factor present in the serum to which the normal 
cells were responding.
1.5 SERUM EFFECT ON TRIGLYCERIDE SYNTHESIS IN NORMAL 
FIBROBLASTS
This effect was, therefore, further characterized. Serum 
medium and hormone medium were compared under exactly the 
same experimental conditions using normal fibroblasts. In 
Figure 10, the effect of oleate concentration on fibroblast 
lipid synthesis is shown over a 4 hour time period. Oleate 
(bound to albumin) was increased systematically from 25 uM 
to 300 uM. Serum concentration in the medium was maintained 
at 2.5 mg protein/ml medium. In the hormone medium the 
concentration of albumin was 1.25 mg/ml, approximately the 
amount present in medium supplemented with 10% (v/v) serum. 
Free fatty acid uptake and incorporation into lipids 
increased as the concentration of oleate in the medium 
increased. However, at each point, oleate incorporation into 
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hormone medium. Similarly, at all incubation times examined 
up to 30 hours, the difference between serum and hormone 
medium was maintained (Figure 11).
Next, the effect of medium composition itself on oleate 
incorporation into total lipids was examined. The data are 
shown in Figure 12. Albumin concentration in the medium was 
maintained constant at 1.25 mg/ml while the non-albumin 
protein in the serum was increased successively from 0 to 
1.25 mg/ml. Care was taken to maintain the albumin
concentration constant in order not to produce effects due
solely to a changing free fatty acid to albumin ratio (92).
Note that oleate incorporation into total lipid was a linear 
function of the amount of non-albumin serum protein,
increasing from 7.5 to 21.6 nmol oleate incorporated/ mg cell 
protein over this range. On the other hand, serum pretreated 
with trypsin did not stimulate oleate incorporation into 
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These studies have shown that fibroblasts can be used 
as a model to study triglyceride synthesis and storage and 
that these cells are consistent and reproducible in their 
response to various media. As a rule, fibroblasts do not 
store phospholipids; phospholipids are synthesized for 
immediate use only, however, the cells will respond to an 
excess free fatty acid influx by esterifying the fatty acids 
to produce storage triglyceride. The major fatty acid in 
adipose tissue triglyceride is oleate, which represents more 
than 50% of total triglyceride fatty acids (86). Oleic acid, 
when incubated with fibroblasts in cell culture, promotes 
triglyceride synthesis and deposition but even at high 
concentrations and for extended periods of time remains non­
toxic to the cells, in contrast to other fatty acids (87). 
It should be noted that the concentrations of fatty acid used 
were well within the physiological range of fatty acid 
concentrations found in plasma . Both medium supplemented 
with serum, and serum-free hormone medium were examined. The 
use of serum-free medium has gained popularity in tissue 
culture because it allows greater consistency in batch-to 
batch preparation, and of greater relevance, it allows 
examination of the effect of serum factors on lipid 
synthesis. Unfortunately, it is not well tolerated by many 
cells. The serum-free medium used here does not represent a 
physiologic medium, since the concentration of supplements,
63
particularly insulin at 2.5 ug/ml is far in excess of serum 
concentrations of 2.5 ng/ml. It was chosen, however, since 
it had been developed for maximal lipid synthesis in human 
skin fibroblasts (71). The data reported above indicate that 
serum can stimulate lipid, and in particular, triglyceride 
synthesis in normal human skin fibroblasts. The factor is 
trypsin-sensitive, non-dialyzable and operates over a wide 
range of fatty acid concentrations and incubation times. The 
effect is suggestive of a protein action and demonstrates a 
concentration dependent response. Additionally, the 
stimulation is specific for lipid synthesis, since hydrolysis 
is not affected, and a general cell proliferative response 
has also been excluded. The lipogenic effect of serum has 
been previously reported. It was shown that pre-adipocyte 
differentiation was dependent on the presence of serum in the 
media, and was species sensitive (89). This effect could not 
be exactly reproduced by inclusion of insulin or other 
hormones in the media. This "lipogenic factor", however, has 
not been characterized or isolated.
However, the responses that characterize the normal skin 
fibroblasts are either absent or markedly attenuated in 
similar cells derived from patients with HyperapoB. This 
difference is present consistently regardless of the marker 
of intracellular triglyceride synthesis used, either the 
fatty acid moiety (UC oleate) or the glycerolipid backbone 
moiety (3H glucose). This is even more striking because lipid
64
synthesis in a hormone medium is identical in both cell 
groups, as are the other cellular parameters that were 
examined. In the absence of LDL in the medium, cholesterol 
esterification in minimal (71). In the presence of LDL, 
cholesterol influx into the cells increases. Cholesterol 
esterification in the HyperapoB cells under these conditions 
was found to be markedly reduced as compared to the normal 
fibroblasts. The difference between normal and HyperapoB 
cells is restricted principally to the acylation reactions 
which produce triglyceride and cholesterol ester, both being 
lipids which are stored intracellularly (Figure 2) .
These findings may have important implications for the 
understanding of intracellular fatty acid metabolism as well 
as further delineation of the pathogenesis and genetic basis 
of HyperapoB. Additionally, the data are consistent with 
previous work which showed a reduction in the rate of fatty 
acid uptake and esterification in adipose tissue from 
HyperapoB patients (33) and Hypertriglyceridemic patients 
(35-37). These findings are also consistent with the 
hypothesis that, in vivo, peripheral tissues in such patients 
do not incorporate free fatty acids at a normal rate, thus 
creating the potential, particularly postprandially, for an 
increased free fatty acid flux to the liver, resulting, in 
turn, in increased VLDL production. These results, therefore, 
support the hypothesis set out in the introduction.
6 5
Clearly, however, before the proposed protein's mode of 
action could be elucidated, or before further testing of 
these hypotheses with respect to HyperapoB, complete 
purification of the active factor had to be achieved.
6 6
2. PURIFICATION AND CHARACTERIZATION OF ASP (ACYLATION 
STIMULATING PROTEIN)
2.1 PURIFICATION OF ASP
Purification of ASP (acylation stimulating protein ) 
was achieved by a three-step chromatographic procedure. At 
each step, the capacity of each column fraction to stimulate 
incorporation of radiolabelled oleic acid into cell lipids 
was assayed using cultured normal human skin fibroblasts as 
described in Materials and Methods. Following defibrination, 
normolipidemic human serum was applied to a dye-binding Affi- 
gel Blue column. This resulted in two fractions, one fraction 
which eluted directly from the column (unbound fraction) and 
a second fraction which remained bound to the column and was 
eluted from the column by addition of 3 M NaCl to the 
starting buffer (Figure 14A). Both fractions were
concentrated, dialyzed and the protein content determined. 
Each fraction constituted about 50% of the recovered protein 
as determined by protein assay. The effect of the fractions 
(1.25 mg protein/ml cell medium) on (UC) oleate incorporation 
into total lipids in normal fibroblasts is indicated by the 
bars in Figure 14A. Virtually all of the acylation 
stimulating activity was confined to the second peak. This 
fraction was then applied to a Sephadex G-75 column 
(Figurel4B) and resolved into two peaks. The first, and by 










































































































































































a molecular weight corresponding to that of albumin. That 
this peak was indeed primarily albumin was confirmed by both 
SDS 15% polyacrylamide gel electrophoresis and by double 
immunodiffusion (95) against anti-albumin antibody 
(Boehringer-Mannheim). Acylation stimulating activity, 
however, was confined to the smaller second peak which eluted 
after the total column volume at Ve/Vo=3.4, pointing to 
interaction of this fraction with the gel. This fraction 
constituted < 1 % of total applied protein and this step 
produced an 80-fold increase in specific activity as compared 
to the starting material, lipoprotein deficient serum (Table 
VI); as well, little activity was lost.
During purification, the object was not only to purify 
the factor to which the normal cells were responding, but 
also to monitor the response (or lack of response) of the 
HyperapoB cells to the serum fraction. These results are 
shown in Figure 15. With incubation times of 4 hours and 24 
hours (not shown), there is consistent stimulation of 
triglyceride (p<0.005, and p<0.01) synthesis in the normal 
cells. Also, at 4 hours, there is significantly higher 
diglyceride (p<0.005) and phospholipid synthesis (p<0.0125) 
in the presence of the serum plasma fraction (30 ug/ml). By 
contrast, lipid synthesis does not increase in the HyperapoB 
cells in the presence of the protein fraction, as reflected 
by triglyceride, diglyceride, and phospholipid synthesis, but 
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trend. In fact, this was also seen when serum medium was 
compared to hormone medium in the HyperapoB cells (Table IV). 
When normal cells are directly compared to HyperapoB cells 
in the absence of serum plasma protein, there is no 
difference in baseline lipid synthesis. However, when lipid 
synthesis between normal cells and HyperapoB cells is 
compared in the presence of the serum protein fraction, there 
is significantly more triglyceride (p<0.05) and phospholipid 
(p<0.025) in the normal cells.
A number of different chromatography media were assayed 
in order to separate the protein fraction into its various 
components. Purification to homogeneity was achieved by 
chromatofocusing in 6 M urea with a pH gradient of 9.7 to 
7.0. This yielded the profile shown in Figure 16A. Acylation 
stimulating activity was predominantly associated (67%) with 
the first peak which emerged at a pH of 8.9 +0.1. A
considerable amount of activity was lost during this step 
(Table VI) possibly due to irreversible inactivation of the 
protein following exposure to urea. In the absence of the 
urea, the fraction emerged from the chromatofocusing column 
as a single peak, which however contained multiple bands by 
SDS gel electrophoresis. Subsequently, this procedure was 
modified and purification to homogeneity was achieved by ion 
exchange chromatography on CM Sepharose at pH 7.5 in 0.02M 
phosphate buffer without urea, as shown in Figure 16B. At 
























column and is subsequently eluted with 1M NaCl in 0.02M 
phosphate. Activity is confined to this bound protein.
2.2 PHYSICAL CHARACTERIZATION OF ASP
When ASP isolated by either chromatofocusing or ion 
exchange chromatography was analyzed by SDS 15% 
polyacrylamide gel electrophoresis with Coomassie Blue R2 50 
staining, a band with a molecular mass of 14,000 ±400 
daltons, n=26 (Figure 17) was demonstrated. Usually only a 
single band was evident but occasional preparations contained 
minor contaminants of 52 and 27 kDa molecular mass. If so. 
a second gel filtration using Sephadex G-75 was employed and 
complete purification achieved. Biologic activity was 
restricted to the fraction which contained the 14,000 
molecular weight protein, which has been named Acylation 
Stimulating Protein (ASP). Of note, a single band was evident 
with both urea/non-reducing SDS conditions as well as 
reducing SDS gel electrophoresis. However, a comparison of 
reducing vs non-reducing conditions (with no urea) reveals 
that ASP migrates slightly more rapidly under reducing 
conditions. Further, as shown in Figure 17, isoelectric 
focusing of ASP using a pH 3-10 gradient also revealed only 
a single band. The pi of this band based either on gel pH or 
by calibration against an isoelectric focusing standard was 
9.0 +0.3 n=5, a value consistent, therefore, with the
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The yield of ASP, the increase in purification, and the 
retention of biologic activity during the purification of ASP 
are summarized in Table VI. Starting with 1.6 g of plasma 
protein (50 ml), 0.5 mg of ASP was obtained, a purification 
of 436 fold, based on specific activity. Total yield of 
activity of the final fraction was 14%.
The physical characteristics of ASP are summarized in 
Table VII. ASP has a molecular weight of 14,000 +400 and a 
pi of 9.0 +0.3. The molecular weight determination from amino 
acid analysis integer residue number optimization is 14,500, 
a value in close agreement with the average SDS 
polyacrylamide gel electrophoresis value. The relative number 
of polar residues of 0.49 is close to the characteristic 
value for a large number of soluble proteins, that is, above 
0.47 (91). The average hydrophobicity, H0=886 calories per 
residue, calculated as described by Bigelow (92) , falls 
within the range for globular proteins. The amino acid 
compositional analysis reveals a high content of cysteine 
residues which may result in intramolecular association via 
disulfide bridges. Some of these cysteine residues in the 
oxidized form may be essential for ASP activity, since when 
ASP purification is performed in buffers containing 2- 
mercaptoethanol, activity is lost. The apparent lower 
molecular weight demonstrated by SDS PAGE under reducing 
conditions also suggests that
7 6
Table VII. 
PHYSICAL CHARACTERISTICS OF ASP
Molecular Weight: PAGE (daltons) 14,000+400
(n=26 determinations) 
pi (n=5 determinations) 9.0+.3
Polarity Index 0 .489
Hydrophobicity HO (cal/residue) 0 .886
Amino Acid Composition:
(purified by Ion exchange chromatography)










































intramolecular cysteine bridges are an important component 
of the structure.
2.3 BIOACTIVITY OF ASP 
The primary effects of ASP on lipid synthesis in normal 
fibroblasts are shown in Table VIII. Following incubation 
for 20 hours in medium containing 10 uM (U C) oleate and 10 
ug/ml ASP, fibroblast lipids were extracted and resolved by 
thin layer chromatography. Oleate incorporation into 
triglyceride, diglyceride and phospholipid constituted at 
least 95% of total fatty acid incorporated into cell lipids. 
In the absence of ASP, triglyceride is the major lipid 
synthesized. In the presence of ASP this trend is even more 
pronounced with the amount of oleic acid entering 
triglyceride synthesis increasing significantly (p<0.0025). 
From the data in Table VIII it is evident that ASP also 
significantly increases diglyceride synthesis (p<0.05). In 
normal fibroblasts, while phospholipid synthesis was 
increased on average, the difference was not statistically 
significant.
The effect of ASP on oleate incorporation into 
triglyceride is linear with incubation periods ranging from 
1 to 24 hours. Interestingly, when linear regression of the 
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occurs at 30 mins, suggesting a lag time before the effect 
of ASP becomes apparent. This is true in experiments 
examining the time relation of triglyceride synthesis over 
both long (Figure 18A) and short time periods (Figure 18B).
As shown in Figure 19 the ASP effect is also present 
over a range in fatty acid concentrations (2-20 uM) with 
the percentage stimulation remaining fairly constant over 
the range (54%). The upper limit of fatty acid concentration 
used was 20 uM, below the critical miceliar concentration 
limit of 25 uM (40).
The effect of varying the concentration of ASP on lipid 
synthesis in normal fibroblasts is shown in Figure 20. With 
increasing amounts of ASP, triglyceride synthesis increased, 
reaching a maximum of 165 +30% stimulation at a concentration 
of 7.5 ug/ml (.54 uM) with a 20 hour incubation. At this 
concentration, the range of stimulation seen in 7 normal 
fibroblasts examined varied from 71% to 228%. This plateau 
level may reflect either saturation of triglyceride synthetic 
enzymes or saturation of membrane receptor-mediated ASP 
action.
As was noted before, in the absence of low density 
lipoprotein (LDL) , relatively little cholesterol ester is 
formed in fibroblasts. The effect of ASP on cholesterol 
esterification was therefore examined in fibroblasts in the 

































































































































































































































































Baseline activity was 6.3 ±1.7 nmol cholesterol ester /mg 
cell protein with LDL as compared to 0.2 +.2 nmol cholesterol 
ester/mg cell protein without. LDL. In Figure 21 it can be 
seen that increasing amounts of ASP stimulate significantly 
the acylation of cholesterol, resulting in a 42% increase in 
cholesterol ester in the presence of 10 ug/ml of ASP. Thus 
ASP not. only stimulates acylation of glycerol and/or 
glycerolipids to form triglyceride and diglyceride, but also 
the acylation of cholesterol to form cholesterol ester.
Various fatty acid binding proteins either of plasma 
origin (albumin) or intracellular origin (fatty acid binding 
protei i-FABP)(47) have been implicated in fatty acid 
transport and lipid synthesis. The effects of albumin (HSA) 
and FABP on oleate incorporation into triglyceride were 
compared simultaneously with those of ASP. As seen in Figure 
22, neither human serum albumin (HSA) nor FABP show any 
stimulatory effect on fatty acid incorporation into lipids 
in fibroblasts. Although the results shown here are at a 
concentration of 15 ug/ml, the effect of these proteins was 
investigated at concentrations varying from 5 to 30 ug/ml, 
and no effect of either albumin or FABP was found at any 
concentration (results not shown). This is in direct contrast 
to ASP which, when present in comparable amounts to the 
albumin and FABP, produces a considerable increase in lipid 













































































































































physical properties cf ASP to those of various cytosolic and 
plasma proteins and apoproteins shows little similarity.
2.4 ASP CELL INTERACTIONS 
These experiments have all examined the effect of ASP 
on triglyceride synthesis with the simultaneous incubation 
of ASP and oleate with the fibroblasts. This raises the 
question as to whether ASP is acting via independent 
interaction with the cells, or solely by increasing fi se 
fatty acid transport across the plasma membrane. If there is 
no specific ASP-cell interaction whatsoever, then a 
preincubation in the presence of ASP alone, without oleate, 
prior to incubation with oleate alone would not be expected 
to affect lipid synthesis. The hypothesis was that ASP would 
enter the cell during the preincubation period and that as 
a consequence, oleate incorporation into triglyceride would 
still be increased even though only free fatty acid and not 
ASP was present in the medium for the second phase. The 
outline and results of such an experiment are shown in 
Figure 23. Cells were incubated with 10 ug/ml of ASP (for 
maximal activity) for various times, followed by a 2 hour 
incubation with 10 uM oleate in the absence of ASP. It was 
felt that a 2 hour time interval provided sufficient time for 
the effect to be measured before all of the ASP could be 




















































































is a substantial increase in triglyceride synthesis mediated 
by the ASP, and that this effect is maximal after 2 hours 
incubation (190 %). Additionally, there is a 30 min lag time 
before the effect of ASP becomes apparent, consistent with 
the previous time curves with ASP (Figure 18A and B).
The interaction of ASP with normal fibroblasts was 
further examined using radio-iodinated ASP and both total 
binding and non-specific binding were measured as described 
in Materials and Methods. At 4°C saturable specific binding 
of 125I ASP is obtained as shown in Figure 24. Specific 
binding constituted 90% of total binding. Scatchard analysis 
of the binding data produces a linear isotherm consistent 
with a single class of binding sites (Figure 24 inset) with 
a Kj OF 9.9 x 10 7 M.
These binding studies indicate a specific receptor 
interaction. This was further examined by pretreating the 
cells in order to hydrolyze the cell surface proteins that 
might be involved in a receptor interaction with ASP (93). 
Following a mild trypsinization, the cells were incubated 
for 4 hours with 10 uM oleate and various concentrations of 
ASP. The results in the absence of trypsin treatment are 
shown in the circles and the results with trypsin treatment 
in the stars in Figure 25. In the absence of ASP (zero 
point) there is little difference in the amount of 























































































































































































































































































untreated cells (all points were assayed in triplicate). 
Additionally, cells were microscopically examined to verify 
cell attachment to the dish and the cells from one dish were 
assayed for viability by Trypan Blue exclusion. In the 
untreated cells, 10 ug/ml ASP produces a 2.5-fold increase 
in radiolabelled triglyceride from 22.5 to *1.9 nmol/mg cell 
protein. In the treated cells, h1 er, there is only a 2 2 
% increase in triglyceride synthesis from 17 to 25.7 nmol/mg 
cell protein. This represents a 78% reduction in the ASP 
activity. These results indicate that ASP does interact with 
the plasma membrane, probably through interaction with a cell 
surface protein, and that this interaction is necessary to 
achieve an ASP effect.
2.5 ASP INTERNALIZATION AND DEGRADATION
An ASP-cell interaction suggests that the ASP may well 
also be internalized and degraded by the cells. To observe 
this, radiolabelled ASP was incubated with normal fibroblasts 
under the same conditions which produced the lipid synthetic 
stimulation. As shown in Figure 26B and C, ASP is both 
internalized and degraded by the cells. Additionally, there 
is concurrent stimulation of triglyceride synthesis as shown 
in Figure 26A. Although the levels of ASP internalized and 
degraded have not reached saturation levels, in spite of 
this, triglyceride synthesis appears to be saturated. This 









































































F  © co ^
^  -o £
D  O  -—  c OT
O S s
CO ^  ^
c E ° 
CD ^  E o § > §
£  w 












limited amount of triglyceride synthetic enzymes available 
in the fibroblast than to ASP metabolism per se. Note that, 
at the maximum level of ASP degradation, this represents only 
2 % of the total medium ASP. However, of the total amount of 
ASP metabolized by the cell (internalized and degraded), 95 
% has been degraded and the metabolites exported to the 
medium, suggesting reasonably rapid turnover of ASP within 
the cell.
This concept was pursued in the following experiment. 
Cells were preincubated with ASP for 18 hours. The medium 
was changed to one containing neither ASP or oleate and the 
cells were maintained in this medium, as shown in Figure 27, 
from 0-5 hours. Next , triglyceride synthesis was measured 
during a 2 hour incubation with KC oleate alone. There is a 
substantial and rapid drop in the amount of triglyceride 
present, implying as would be expected from the 
radioiodinated ASP data, rapid degradation of ASP by the 
cell.
The ASP effect therefore appears to be mediated through 
interaction with the plasma membrane, and ASP is in turn 
hydrolyzed within the cells. This satisfies the requirements 
both for a hormone mediated action and for a transport 
process. However, this does not answer the question as to 
whether internalization of ASP is necessary to provoke the 
metabolic response. To examine this issue, fibroblasts were 


















































































































































































































endocytosis. This was achieved by incubation in the presence 
of 5 uM monensin (57) or at 17°C (58), with or without ASP. 
As shown in Figure 28, with untreated cells ASP stimulates 
triglyceride synthesis by 180%. Incubation with monensin or 
incubation at a temperature of 17°C, both of which 
effectively block endocytosis, also completely block the ASP 
effect. These results imply that internalization of the 
protein is necessary for it to achieve its specific effect 
on the fibroblasts.
2.6 DISCUSSION
ASP is a small (14,000 Da), basic (pi 9.0) protein which 
has been purified 436 fold from - human plasma to yield a 
homogeneous protein. The data presented above establish that 
ASP, a purified plasma protein, stimulates triglyceride 
synthesis and cholesterol esterification in cultured human 
skin fibroblasts. The effect is time-dependent and
concentration dependent and is consistent with the results 
that were obtained using serum medium. In addition, the 
effect is demonstrated over a range of free fatty acid 
concentrations (2-20 uM) . Although the experiments were 
performed with free oleate at low concentrations, previous 
experiments with serum medium showed that a similar effect 
was achieved when cells were incubated with higher 
concentrations of oleate complexed to albumin. The
concentration of oleate used in the majority of the 
experiments (10 uM) is the calculated amount of free fatty 
acid present in a solution of 100 uM oleate complexed to
albumin at a molar ratio of 6:1 (39).
The hypothesis is that specific binding to the plasma 
membrane appears essential to the metabolic mechanism of 
action of ASP (Figure 29). Trypsin pretreatment of the cells 
eliminates the ASP specific response indicating that ASP-cell 
interaction is necessary for the effect. In addition, ASP is 
internalized and degraded by fibroblasts. Hormones, for 








































































































intracellular lipid synthesis with catecholamines stimulating 
lipolysis (54), insulin promoting synthesis (53). That ASP 
stimulation exceeds that of insulin (53,63), where insulin 
has previously been thought to be the most potent known 
stimulator of triglyceride synthesis, has been demonstrated 
above. Certain cytosolic proteins have also been reported to 
increase microsomal triglyceride (94), cholesterol (46,47) 
and cholesterol ester (95) synthesis. However, none of these 
proteins examined appear to be physically similar to ASP, 
and, in this experimental system, one of these proteins, 
fatty acid binding protein (FABP), did not mimic the action 
of ASP. Therefore, altering intracellular lipid synthesis to 
this extent, consequent to the action of an extracellular 
protein, appears to be a novel observation.
What mechanism or mechanisms might be responsible, and 
why would the effect be more obvious for storage lipids such 
as cholesterol ester and triglyceride, but not as marked for 
those such as phospholipids which are not stored, but used 
immediately in the cell's ongoing metabolism? Since hormones, 
specifically insulin, have been shown to increase fatty acid 
esterificaton to form triglyceride, a stimulation which is 
not secondary to increased glucose transport, it is possible 
that ASP is operating in the same manner. Surprisingly, in 
spite of extensive research into the mechanism of action of 
insulin, the process by which it acts is still far from 
understood. Nonetheless, insulin appears to act on cells
100
primarily through interaction with the plasma membrane. In 
marked contrast with insulin, there is no ASP effect in the 
absence of internalization of ASP as shown in Figure 28. And 
indeed, the experiments designed to inhibit endocytosis 
indicate that the metabolic effect of ASP occurs after its 
interaction with the cell membrane, presumably after it 
actually enters the cell itself. These data therefore are 
not completely consistent with the hormonal model in which 
the ultimate intracellular effect occurs consequent to a 
secondary messenger cascade initiated solely by the initial 
ligand-plasma membrane receptor interaction. In addition, 
the effect of insulin is rapid, whereas the effect of ASP 
exhibits a 30 minute lag time before the effect is apparent, 
a phenomenon more characteristic of a process which involves 
secondary processing. This model is supported by the similar 
time lag before the drop in ASP effect (Figure 27) although 
this does not necessarily differentiate between hormone vs 
non-hormone mediated actions. Additionally, direct activation 
of the enzymes involved in triglyceride synthesis occurs by 
dephosphorylation (45) while acyl-cholesterol-acyl- 
transferase activity is increased by a phosphorylation 
reaction (96) . Thus it is unlikely that a single stimulus 
acting in such a manner directly on enzymes would promote 
both reactions.
The data suggest that ASP enters the cell as a 
consequence of specific receptor binding (Figure 29) . This
101
conclusion is based on the studies of binding, 
internalization and degradation using iodinated ASP. Clearly, 
endocytosis is also necessary in order to mediate the ASP 
action. With regard to triglyceride synthesis, the data make 
it clear that it is the synthesis of the total glycerolipid 
molecule that is affected by this activity, not merely re- 
esterification and/or glucose uptake into the cell. In 
general, enzyme reactions are product-inhibited, providing 
economical self-regulation. However, synthesis of cholesterol 
ester and triglyceride to be stored within cells cannot be 
so regulated, and control of these processes much more likely 
rests on substrate availability.
Theoretically, the protein might influence free fatty 
acid uptake into the cell and subsequent transport within 
the cell, or activity of the triglyceride synthetic enzyme 
complex located within the smooth endoplasmic reticulum. More 
is known of the last step than the first. Thus the processes 
by which free fatty acids enter cells remain surprisingly 
controversial, with most opinion favoring passive or 
membrane protein mediated diffusion (40-43) , although others 
still suggest that binding of albumin to specific receptors 
occurs first, followed by inward transfer of free fatty acid. 
Similarly, how free fatty acid moves from the cell membrane 
through the cytoplasm to be targeted either to the 
mitochondria or smooth endoplasmic reticulum also remains 
unclear, although such a role has been suggested for certain
102
intracellular fatty acid binding proteins (46,47). However, 
there is no evidence that ASP is acting primarily by 
increasing free fatty acid entry into the cell. In the first 
place, its fatty acid binding properties are weak and non­
specific (personal communication, M.A. Rodriguez) and in the 
second, as shown in both preincubation experiments (Figures 
23 and 27), the metabolic effect of ASP is evident, even if 
no free fatty acid is present during preincubation. Lastly, 
other fatty acid binding proteins, both plasma and 
intracellular (albumin and fatty-acid-binding-protein), have 
no apparent effect on triglyceride synthesis.
Though the effect of ASP seems clear, its mechanism of 
action is not, and that is of considerable interest.What is 
apparently left is a protein that does not appear to work as 
a hormone, nor does it apparently work as a transport protein 
in the classical concept. The substrate availability at the 
critical intracellular site, the endoplasmic reticulum, may 
well be an important control of the synthetic rate of storage 
lipids. The hypothesis that will be tested in future studies 
is that the plasma protein, ASP, responsible for the 
activities identified here, has its impact principally on the 
presentation of substrates: specifically acyl-CoA, to the 
enzymes in the smooth endoplasmic reticulum. Although the 
precise mechanism of action of ASP remains to be elucidated, 
ASP may well be important in the regulation of intracellular 
triglyceride synthesis.
1 0 3
3. ASP EFFECT ON HYPERAPOB FIBROBLASTS
3 . l T R i G L Y c m P P . j m B E B&PQP
ASP has been shown to have a marked effect on 
triglyceride synthesis in normal cultured human skin 
fibroblasts. In addition, the data suggest that ASP is bound, 
internalized and degraded by the cells. Preliminary 
investigations with respect to its mechanism of action 
indicate that the protein produces its effect on the cells 
only after endocytosis. This stands in contrast to a 
classical hormone effect, further the data also do not 
support the model of a typical transport protein (Figure 30).
The initial experiments designed to compare lipid, and 
in particular, triglyceride synthesis in normal vs HyperapoB 
fibroblasts demonstrated that, using serum (Figure 4) or 
partially purified protein fraction (Figure 15) , the 
HyperapoB cells did not respond to the stimulus in the 
supplemented media, whereas the normal cells did. Following 
purification of ASP, the HyperapoB cells were examined for 
their response to ASP.
The plasma lipid values for the normal and HyperapoB 
subjects are given in Table IX and X. The definition of 
HyperapoB is based on increased plasma LDL apoB accompanied 
by an LDL cholesterol to apoB ratio less than 1.5:1.0 (68) 
and is principally a functional definition. It can be seen 
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to 1, ranging from 0.67 to 1.45. Average plasma cholesterol, 
LDL cholesterol, plasma triglyceride, and LDL apoB were all 
significantly higher in the HyperapoB patients. HDL 
cholesterol, however, was not different.
The ASP effect on triglyceride synthesis is shown in 
Figure 31. In the normal cells, with increasing 
concentrations of ASP, there is an increase in triglyceride 
synthesis, reaching a maximum of 180 % of baseline (range 
131 to 270), that is a stimulation of 80%. In contrast, the 
HyperapoB cells demonstrate much less response to ASP, with 
an average maximum activity 125% (range 78 to 187%), that 
is, 25% stimulation. It should be noted that the absolute 
baseline values, that is, nmol of triglyceride synthesized 
per mg cell protein in the absence of ASP, are no different 
between normal and HyperapoB cells. The metabolism of 
iodinated ASP was followed concurrently with the effect on 
triglyceride synthesis. The amount of ASP that was associated 
with the cells at time of harvest was determined, as was the 
amount of ASP that had been degraded by the cells during the 
incubation period, which in all cases was 24 hours. The 
results indicate that much less ASP had been degraded by the 
HyperapoB cells (Figure 32B). Similarly, although not as 
pronounced, there is a trend towards less ASP associated with 
























































































































































































































































































represents ASP which may be bound to the cell surface as well 
as internalized in the cells.
3.2 ASP BINDING TO HYPERAPOB CELLS
At 37°C, proteins that bind to cells may be internalized 
and degraded. However at 4°C, proteins will bind to cells, 
but will not be internalized and metabolized by the cells 
(82). The interaction of the protein with the cells can be 
either specific, or non- specific. Non-specific binding, or 
association of a protein to the cells is via interaction with 
the cell membrane surface. Specific binding is the 
interaction of a protein with a particular membrane protein 
on the cell surface. The membrane protein is present at a 
fixed concentration, and binding of ASP is, therefore, a 
saturable process. Binding of ASP to normal and HyperapoB 
fibroblasts has been examined. The results shown in Figure 
33A indicate that ASP binds saturably and specifically to 
both normal and HyperapoB cells. However, although the 
binding of ASP to the HyperapoB fibroblasts is saturable, 
that saturation is attained at half the maximum level of the 
normal cells. A Scatchard analysis (Figure 33B) permits 
quantitation of both affinity constants and estimates of 
receptor number. Overall, the HyperapoB cells demonstrate the 
same binding affinity for ASP as the normal cells as 















































































































































































































































HyperapoB), however the x intercept on the graph, resulting 
from linear regression of the data, indicate that the number 
of binding sites is half that seen in the normal cells, the 
value for the normal cells being 1.217 mg'1 and for the 
HyperapoB cells 0.621 mg'1. The individual values for the 
normals and HyperapoB cells are given in Table XI) . It is 
interesting to note that although the binding of ASP to the 
HyperapoB cells appears to be half normal, the resulting 
triglyceride stimulation appears to be less than half that 
of the normal cells. One possible explanation for this is 
that the ASP in the medium, which is being taken up to a 
lesser extent by the HyperapoB cells, is acting as a fatty 
acid sink even though the fatty acid binding properties 
appear to be weak and non-specific. Therefore, reducing the 
effective fatty acid concentration available to the cells.
3.3 CHOLESTEROL ESTERIFICATION IN HYPERAPOB
Previously, it has been shown that ASP can also 
stimulate another acylation reaction, cholesterol 
esterification, when the cells are incubated under the 
appropriate conditions . This was also examined for the 
HyperapoB cells under the same conditions (Figure 21). In 
the absence of LDL cholesterol ester formed is .2 +.2 
nmol/mg cell protein in the normals and 1.4 +.4 nmol/mg cell 











































































































































but without ASP cholesterol ester formed is 6.3 ±1.7 nmoles 
CE/mg cell protein in the normal cells vs 7.3 +.9 nmoles/mg 
cell protein in the HyperapoB cells. However, as was the case 
for triglyceride synthesis, in the presence of ASP, HyperapoB 
cells also esterified less cholesterol than the normal cells 
(Figure 34), consistent with the results found using 
lipoprotein deficient serum (Figure 6).
3.4 TRIGLYCERIDE SYNTHESIS IN CELL HOMOGENATES
If the HyperapoB cells are less responsive due to a 
decreased complement of receptors, and therefore an inability 
to internalize the ASP, then it is of interest to examine 
lipid synthesis in a cell free system, that is in a cell 
homogenate, where the ASP is available to the triglyceride 
synthetic enzymes. As shown in Figure 35, there was no 
apparent difference in triglyceride synthesis in the normal 
cells as compared to the HyperapoB cells. However, the amount 
of stimulation is relatively low in both the normal and 
HyperapoB homogenates, although this may simply be a function 
of the assay conditions (for example the short incubation 
time).
3.5 ASP EFFECT IN FH FIBROBLASTS
Therefore, the HyperapoB cells are consistently less 
responsive to ASP than the normal for both triglyceride 
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decrease in stimulation can be explained by a reduced amount 
of ASP bound and internalized by the cells. The question then 
is, is this a specific characteristic of HyperapoB cells, or, 
since all of these cell lines were derived from patients with 
coronary artery disease, is this lack of response to ASP a 
more general phenomenom unrelated to the dyslipoproteinemia 
HyperapoB. Accordingly, cells derived from patients with the 
homozygous or heterozygous form of Familial 
Hypercholesterolemia were examined for their response to ASP. 
Three patients had heterozygous FH as defined by total plasma 
cholesterol and LDL cholesterol above the 95th percentile and 
an LDL cholesterol-to-LDL apoB ratio greater than 1.8 to 1 
(68) (Table XII). All of the plasma parameters are 
significantly increased as compared to the normals (Table 
XIII). Three other cell lines were obtained from the ATCC 
(American Tissue Culture Collection) and these cell lines 
were from adult patients with homozygous FH as determined by 
LDL receptor binding studies which indicated that their cells 
contained no functional LDL receptors. Therefore, these cells 
are derived from patients whose phenotypes demonstrate 
increased circulating levels of LDL apoB, but this increase 
is due to a decreased catabolism, as opposed to an increased 
production.
The response of the FH cells to ASP is shown in Figure 
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Figure 38. ASP BINDING DISTRIBUTION IN ALL SUBJECTS
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concentration to an average maximum of 155% stimulation 
(range 89 to 250%) and there is no apparent difference 
between the normal and the FH. Additionally, baseline 
synthesis is similar to that seen in the normal and HyperapoB 
cells . Specific binding of ASP and Scatchard analysis of the 
specific binding also show very similar results to the normal 
cells (Figure 37A and B). There is no indication that the FH 
heterozygotes, or the FH homozygotes demonstrate any 
difference in ASP binding or subsequent triglyceride 
response.
3.6 ASP BINDING DISTRIBUTION
All of the data to date on ASP effect on triglyceride 
synthesis and ASP binding in the normal, HyperapoB and FH 
cells have been shown as averages of groups. This however, 
provides very little insight into the range of the response 
to ASP, the consistency of response within a cell line, and 
additionally the association between binding and triglyceride 
synthesis, or conversely, reduced binding and lack of 
triglyceride synthesis. Ultimately, the goal is the
classification of the individual cell lines based on ASP 
response, with respect to ASP binding and triglyceride 
synthesis.
The values for the ASP saturation binding and for the 
ASP triglyceride response are an average of at least 2-3 
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experiments for both binding and triglyceride response in 
each of the cell groups is 26% and 14.5% for the normals, 
16% and 17% for the HyperapoB and 16% and 13% for the FH 
group. Note that the deviation is relatively the same for 
each of the 3 different ce’ groups.
In Figure 38, the distribution of the saturable ASP
binding levels is shown for each of the three cell groups.
The level of saturable ASP binding is the plateau level of 
the specific binding curve as shown in Figures 33A and 37A. 
It is normally estimated by linearization by Scatchard 
analysis and the x axis intercept is calculated by linear 
regression as shown in Figures 33B and 37B. Each cell line 
was assessed individually (as shown in Table XI, and the 
average for all of the normal cell lines was determined. 
Using this as the 100% level, the saturable binding level 
for each of the normal, HyperapoB and FH cell lines was 
determined. The normal cell lines range from 60% to 14 0% of 
the normal average. The HyperapoB cell lines average 63% + 
7 of the normal cell lines, ranging from 11% to 80% of the 
normals (p<0.0025). Note that 8 of the 11 cell lines fall 
outside of the normal range of ASP binding (defined as
average + 1 standard deviation). In contrast, the FH cell
lines fall primarily within the range of the normals, average 
FH binding 87% +8 (p N.S.). Of the 6 cell lines examined, 5 
are within the normal range. A similar
1 2 5
Table XII, SCATCHARD 
LINEAR REGRESSION ANALYSIS
CELL # SLOPE INTERCEPT CORRELATION
NORMAL
2000 - .050 1.680 ,49
6000 -.054 .780 .70
9000 -.087 1.157 .62
6600 -.125 1.207 .82
1000 - .058 1.153 .74
2700 - .053 1.454 .79
0000 - .050 1.760 .60




3000 - .066 1.242 .66
4000 - .080 .760 .86
5000 -.062 .660 .80
4500 - .053 .740 .55
9500 - .098 .810 .90
1100 - .013 1.260 .47
1500 - .053 .720 .48
1400 - .046 ,110 .65
2400 - .049 .610 .42
2600 - .266 .750 .90
average - .080 .760 .67
s.e.m, +.02 + 10
p value N .S . « .0025
Scatchard analysis of binding Isotherms by least 
squares linear regression in normal and HyperapoB 
cell lines as described in materials and methods,
distribution of the ASP effect on triglyceride synthesis was 
obtained.
Lastly, the association of ASP binding with the 
subsequent triglyceride synthesis stimulation was examined 
for all of the cell lines. If there is a direct link between 
ASP binding and internalization into the cells and a 
subseguent stimulation of triglyceride synthesis, then a 
linear correlation would be anticipated. And indeed, as shown 
in Figure 39, there is a strong linear relationship between 




Compared to the results obtained in normals, decreased 
responsiveness to ASP occurred in the skin fibroblasts 
cultured from patients with HyperapoB. The findings in terms 
of altered binding and altered cell metabolic response were 
concordant. That is to say, in HyperapoB, specific binding, 
internalization, and degradation were all reduced, and these 
changes correlated with decreased triglyceride synthesis by 
the HyperapoB fibroblasts. These findings support the 
hypothesis that the metabolic effect of ASP is dependent upon 
specific interaction with the cell.
These results may provide the opportunity to determine the 
genetics of HyperapoB itself. It has been established that 
HyperapoB is a familial disorder with roughly one child in 
three at risk being affected (19). This, of course, does not 
mean that HyperapoB is genetic in origin. The many points of 
similarity between HyperapoB and Familial Combined 
Hyperlipidemia have been noted. The latter disorder was 
originally characterized by multiple lipoprotein phenotypes 
within a family and thought to be autosomal dominant in 
character (20). Only recently has an elevated apoB been 
recognized as the common thread amongst those affected with 
this disorder (21). The genetics of disorders with variable 
expression plus variable age of expression is complex to say 
the least. If reduced ASP responsiveness is sustained as 
characteristic of at least a subset of patients with
1 2 8
HyperapoB, it will allow independent,and hopefully, less 
ambiguous examination of the genetics of HyperapoB. It will 
at the same time allow the issue to be settled as to whether 
if ever, and if so , how often, HyperapoB and Familial 
Combined Hyperlipidemia are one and the same disorder.
These results are important as well in that they sustain 
the hypothesis that peripheral fatty acid metabolism is 
abnormal in HyperapoB. They are consistent with the 
observations of a reduced rate of triglyceride synthesis in 
adipocytes from patients with HyperapoB as well as the 
observations of a reduced rate of clearance of chylomicron 
triglyceride in patients with HyperapoB. If the rate of fatty 
acid uptake in key peripheral tissues were, indeed, reduced 
in patients with HyperapoB then increased influx to the liver 
and subsequent increased hepatic apoB production by the liver 
would be possible. It should be noted that although such 
results are consistent with the thesis, they by no means 
establish it.
In summary, these data indicate that a decreased 
response to ASP is characteristic of the HyperapoB cells. In 
contrast, FH cells demonstrate no abnormal response to ASP.
The association between dyslipidemias and heart disease 
is now a well defined and well accepted concept (4-8). The 
search for the underlying causes of elevated levels of 
lipoproteins in the circulation has focused on the two
hypotheses of reduced peripheral tissue catabolism and 
increased hepatic production.
As a result of the studies of Brown and Goldstein (14) 
that demonstrated reduced LDL catabolism and reduced 
cholesterol esterification in FH patients, other groups have 
also examined LDL binding and/or cholesterol esterification 
in peripheral tissues in patients with other dyslipidemias 
or patients with coronary artery disease using human skin 
fibroblasts as a model. However, to date, the only other 
abnormality described has been the recently described 
defective apoBlOO, which is a defect in the lipoprotein 
particle, and not the cellular receptor (15,16).
No studies have examined lipid synthesis, and in 
particular triglyceride synthesis in human skin fibroblasts 





The observation that normal lipoprotein deficient serum 
stimulates triglyceride synthesis in human skin fibroblasts 
more than serum free media was serendipitous. The decision 
to pursue it was not. A committed effort to identify the 
factor responsible led to the purification and initial 
characterization of a unique plasma protein responsible for 
the metabolic effects on these cells. The protein has not 
previously been recognized, and has been named Acylation 
Stimulating Protein. ASP is a small molecular weight (14,000 
daltons) basic (pi 9.0) protein that stimulates triglyceride 
synthesis in normal human skin fibroblasts.
Relatively little is known about the regulation of 
triglyceride synthesis, such that to date, insulin has been 
the only substance known which car; stimulate fatty acid 
esterification to increase triglyceride synthesis. ASP, 
however, stimulates triglyceride synthesis to a much greater 
extent than insulin under the experimental conditions used.
The effect of ASP was first recognized in experiments 
designed to examine lipid synthesis in normal fibroblasts 
under defined conditions. In the presence of lipoprotein 
deficient serum medium, triglyceride synthesis was greater 
than in the presence of a serum-free hormone supplemented 
medium. This effect was trypsin sensitive, and not affected 
by dialysis. Further, the effect was dependent on the
1 3 1
concentration of lipoprotein-deficient serum in the medium, 
and apparent over a wide range in fatty acid concentration 
and incubation times.
A partially purified protein fraction was achieved 
through column chromatography using Affi-gel partitioning, 
followed by molecular weight gel filtration. Although this 
fraction contained 76% of the activity, it was composed of 
multiple proteins. Initial attempts at further purification 
using various chromatographic media did not successfully 
separate the different protein components of this partially 
purified fraction. Ultimately, however, complete purification 
was achieved by chromatofocusing with a pH gradient. 
Subsequently, this final step was modified, and complete 
purification is now acheived through the use of a CM 
cellulose ion exchanger.
The experimental data demonstrate that ASP stimulates 
triglyceride synthesis in a concentration dependent manner 
over a range of fatty acid concentrations and incubation 
times. Under appropriate conditions, in the presence of LDL, 
cholesterol esterification is also stimulated. Moreover, ASP 
is bound by specific high affinity receptors following which 
it is internalized and then degraded by fibroblasts.
In contrast to the stimulation of triglyceride synthesis 
seen in the normal cells, cells derived from patients with 
HyperapoB are much less responsive to ASP. This lack of 
response is paralleled by a decrease in specific ASP binding.
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However, cells derived from patients with Familial 
Hypercholesterolemia demonstrate normal binding and 
triglyceride stimulation comparable to the normal cells.
ASP response may not only serve as a cell marker for 
HyperapoB but may also be important in the pathophysiology 
of HyperapoB. Previous work has shown that HyperapoB is 
characterized by a decreased clearance of chylomicrons (34), 
and in vitro studies have suggested that this may be due to 
a reduced uptake of fatty acids by peripheral tissues (33). 
These results suggest, first, ASP may be important in vivo 
in the clearance of triglyceride from the circulation through 
stimulation of fatty acid uptake and esterification, and 
second, if the peripheral tissues of HyperapoB patients have 
a decreased response to ASP, then there may be an increased 
fatty acid flux to the liver. This in turn may result in the 
overproduction of hepatic apoB containing lipoproteins whicn 
is characteristic of HyperapoB (24) .
Experiments have been undertaken to examine the mechanism 
of action of ASP. Preliminary results indicate that ASP must 
be internalized in order to produce its metabolic effect, 
since blocking endocytosis also blocks this effect. This, of 
course, stands in marked contrast to the effect of insulin 
on triglyceride synthesis which is mediated primarily through 
interaction with the plasma membrane. Moreover, this 
hypothesis is consistent with the time lag evidenced before
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a metabolic effect is apparent. ASP does not, therefore, 
appear to be acting via a classical hormone mechanism.
Similarly, ASP does not appear to be acting either 
solely, or even principally, to transport fatty acids into 
the cell, since preincubation of the cells with ASP in the 
absence of fatty acids serves to prime the cells, such that 
in a subsequent incubation with fatty acids and no ASP, the 
level of triglyceride synthesis is increased. Thus ASP 
appears to be acting via a mechanism other than the two well 
characterized classical pathways. Obviously, though, the 
exact mechanism by which ASP acts must be explored in depth 
in further experiments.
ASP: ADDITIONAL INFORMATION
The present body of work deals solely with the effect 
of ASP on human skin fibroblasts. However the action of ASP 
has also been investigated in other systems, and this 
associated work is presented here in order to provide a more 
comprehensive overview of ASP and its possible mechanism of 
action. The action of ASP has also been investigated in 
primary human adipocytes (62,63). As in the fibroblasts, 
there is a marked effect on triglyceride synthesis, but to 
a much greater extent. Since ASP is bound, internalized and 
degraded, it was of interest to examine the effect of ASP 
directly at the site of triglyceride synthesis. Microsomal 
fractions were prepared from human adipose tissue and assayed
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for the effect of ASP on fatty acid incorporation into 
triglycerides. Marked stimulation which was significantly 
greater than that seen in the fibroblast homogenates, was 
observed (unpublished data).
LIMITATIONS
There are certain limitations to the work which must be 
enunciated. Preliminary evidence, based on the physical 
characterization to date, indicates that the protein appears 
to be a unique protein. However, to confirm this, and also 
to further characterize the protein and its site(s) of 
synthesis, its amino acid sequence must be determined and 
compared to that of other proteins, not only to determine if 
this is a unique protein, but also to elucidate information 
about its structure and function based on comparison analysis 
with proteins of known amino acid sequence, structure and 
function.
Although preliminary experiments on the mechanism of 
action of ASP have been completed, a detailed experimental 
analysis of the mechanism of action of ASP is required.
Additionally, and more importantly, all of the evidence 
to date deals with the effect of ASP on in vitro cell 
systems, the cultured human skin fibroblast and the primary 
isolated adipocyte. It remains to be seen whether, in the 
organism as a whole, ASP will exert a physiological effect. 
Since ASP is a plasma protein, a first step will be to
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quantitate its levels in plasma and to examine whether these 
levels can be modified under conditions that are relevant, 
such as dietary fat loads. To that end, a polyclonal antibody 
has been produced, and a preliminary assay has been 
developed. It should be noted that, based on the estimate of 
ASP in plasma using this antibody assay, the experiments to 
measure the ASP biological response were conducted under 
physiological ASP concentrations.
ASP: HYPOTHESIS
It would appear that ASP is acting in a unique manner 
to stimulate triglyceride synthesis and it is interesting to 
speculate on the possible mechanism of action (Figure 29). 
The present hypothesis is an attempt to integrate the 
function of ASP with other recent published experimental work 
on fatty acid uptake and esterification. This suggests that 
fatty acid enters the cell via either diffusion or a membrane 
receptor. Once within the cell these may be transported via 
fatty acid binding protein to either the mitochondria for 
oxidation or the microsome for esterification. At the 
microsome, the fatty acid must be activated by acyl CoA 
ligase, before partaking in the series of enzymatic reactions 
that produce triglyceride. ASP, in turn, is bound to the cell 
membrane via a specific receptor, and is endocytosed into the 
cell. One hypothesis is that ASP is acting directly at the 
site of triglyceride synthesis, the smooth endoplasmic
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reticulum, to stimulate the enzymes involved, possibly by 
improving substrate presentation (specifically acyl CoA ) or 
by some effect on the membrane enzymes themselves such as 
acyl CoA ligase, glycerol-phosphate-acyltransferase (gpat) 
or diacylglycerol-acyltransferase (dgat) and this is 
currently th'? working hypothesis for the mechanism of action 
of ASP.
The concept of intracellular targeting of ligands is 
not new, but very little has, in fact, been elucidated 
concerning this mode of action. This v*ould also imply a 
specific plasma membrane receptor protein in order to effect 
this targeting. Thus, with respect to the mechanism of action 
of ASP, a great deal of experimental work remains to be done.
ASP may not only be relevant physiologically, but also 
pathologically. The lack of response of the HyperapoB cells 
demonstrates that there is a specificity to the action of 
ASP, and that it may play a part in HyperapoB. In contrast, 
cells derived from patients with FH responded normally to 
ASP. As outlined above, a reduced ASP receptor number in 
HyperapoB may help to explain the increased levels of LDL 
apoB. Since the postulated defect in some cases of HyperapoB 
is suggested to be based on a reduced response to ASP, it is 
interesting to imagine what might be the effect of an 
increased response to ASP, or to the effect that increased 
levels of plasma ASP might have on the organism. Obesity, as 
a potential example of the latter, immediately comes to mind.
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In conclusion, ASP is a small, basic human protein that 
has been purified from human plasma. ASP stimulates 
triglyceride synthesis in both normal skin fibroblasts and 
FH fibroblasts, an effect that is mediated through specific 
binding and uptake into the cells. In contrast, HyperapoB 
cells show markedly reduced response to ASP both with respect 
to triglyceride synthesis stimulation and ASP specific 
binding.
ASP, therefore, may be relevant not only in the 
pathogenesis of HyperapoB, but may also be important 
physiologically in the regulation of triglyceride synthesis, 
and also, and at least of equal interest, ASP may yield 
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